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ABSTRACT 
In recent years mass spectrometry has become an invaluable tool to address an 
array of biological questions. The versatility of this experimental approach does not only 
allow assignment of protein identity and identification of sequence specific modifications, 
but with the help of particular derivatization techniques facilitates the determination of 
peptide quantity. Each of these approaches were applied to the following biological 
projects: 
The 21 kDa heat stable protein purified from the encysted embryo of Artemia 
franciscana was characterized by time-of-flight mass spectrometry. De novo sequencing 
of peptides identified this protein as a group 1 Late embryogenesis abundant (LEA) 
protein. The amino acid sequence assignment to these peptides allowed amplification of 
the entire gene sequence from an embryonic cDNA library. This was deposited into the 
NCBI database (EF656614). The expression of group 1 LEA protein is consistent with 
and supports a role in desiccation tolerance. In addition, this is a first report describing 
identification of a group 1 LEA protein in an animal species. 
A MS-based quantitative analysis was performed in order to analyze relative 
changes in the dynamic thiol and disulfide states of the redox sensitive protein disulfide 
isomerase, PDI. PDI cysteine residues were derivatized with an isotope-coded affinity tag 
(ICAT), thus allowing a direct comparison between the reduced and auto-oxidized forms. 
Quantitation was based on relative ratios between light and heavy isotopically labeled 
cysteine containing peptides. The application of the ICAT-labeling approach to PDI 
related studies, allowed direct assignment of individual cysteine residues and their 
oxidation status, compared to the previously employed techniques, that only provided 
vii 
information regarding the average number of modified cysteine residues within PDI, not 
their exact identity. 
A combination of a phosphopeptide enrichment step and a MS-based approach 
was utilized to identify three phosphorylation sites on hYVHl, an atypical dual 
specificity phosphatase that functions as a cell survival factor. With the help of 
phosphomimetic and non-phosphorylable mutants, we were able to decipher their effect 
on localization and progression through the cell cycle. 
Collectively, these studies manifest the power of MS-generated data to influence 
and guide many different fields ranging from molecular embryology to biochemistry. 
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Recent advances in mass spectrometry have brought this technique to the forefront 
of discovery based system biology research. Since a major theme of this dissertation is 
the application of different mass spectrometry based approaches to answer significant 
biological questions, an overview of several different mass spectrometry based 
approaches will be discussed, including methods employed during this dissertation. 
ABC's of mass spectrometry 
Mass spectrometry (MS) in recent years has become a fundamental experimental 
approach in biochemistry. Mass spectrometers by definition measure mass-to-charge ratio 
(m/z) of ionized analytes (Figure 1) [1]. A mass spectrometer is characterized by three 
major components, an ion source, a mass analyzer and an ion detector (Figure 2A). 
Originally, MS was restricted to measurement and analysis of small and 
thermostable molecules, because large organic molecules (such as peptides and proteins) 
would undergo extensive fragmentation and decomposition upon vaporization into the gas 
phase [2]. This was overcome by the development of "soft" ionization methods (where 
ions are created with low internal energy and thus undergo limited fragmentation), such 
as electrospray ionization (ESI) [2] and matrix assisted laser desorption/ionization 
(MALDI) [3]. These two ionization methods are fundamentally different. In the case of 
ESI, a liquid sample is injected through a needle and the surface of the emerging liquid is 
charged by an electric field, thus forcing it into a fine spray of charged droplets [2], 
thereby producing a continuous beam of ions (Figure 2B) [4]. In the case of MALDI, the 
gas phase ions are produced from a dry co-crystallized liquid sample with an organic 
matrix [3]. The energy from the laser is deposited into the matrix causing rapid thermal 
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Figure 1. A simplified version of a Mass spectrometry (MS) experiment 
A protein sample is prepared by an appropriate purification protocol dependent on both, 
the type of biological question being asked, and the sample source (e.g. cultured cells, 
bacterially purified protein or tissue samples). The sample is then subjected to enzymatic 
proteolysis by common proteases such as trypsin, GluC, Lys-C and Asp-N. Generated 
peptides are then ionized by electrospray ionization (ESI) or matrix-assisted laser 
desorption/ionization (MALDI) for subsequent analysis by the mass spectrometer. 
Ionized peptides are detected in MS mode as a peptide fingerprint and the MS/MS mode 
provides information regarding the amino acid sequence of a particular peptide. 
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Figure 2. Basics of peptide ionization and time-of-flight instruments 
(A) The three major components of a mass spectrometer. (B) A schematic depiction of 
the ionization process in a typical electrospray instrument, ESI. (C) A schematic 
depiction of the ionization process by matrix-assisted laser desorption/ionization, 
MALDI. (D) A simplified schematic of a MALDI time-of-flight (TOF) instrument. The 
ions are first accelerated to high kinetic energy allowing separation based on their 
different velocities along the flight tube. The detector amplifies and records arriving ions. 
(E) A simplified schematic of a MALDI TOF/TOF instrument. A collision cell has been 
incorporated between the two TOF sections. 
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producing packets of ions (Figure 2C) [4]. Another common distinction for peptide 
analysis is that mainly singly charged ions are generated upon MALDI, whereas ESI 
generates multiply charged species [5]. 
There are currently four basic types of mass analyzers for the study of peptides 
and proteins; time-of-flight (TOF), ion trap, quadrupole and Fourier transform ion-
cyclotron (FTICR) [1, 6, 7]. The separation of ions in these mass analyzers is based on 
flight time (TOF instruments), stability (quadrupoles) and resonance frequency (ion traps, 
orbitraps, FTICR instruments) [5]. Each analyzer has a characteristic behaviour with 
regards to resolving power, sensitivity and dynamic range. In a quest to make the 
analyzers better and more versatile, a new generation of 'hybrid' instruments have been 
introduced. These instruments containing a parallel configuration of more than one 
analyzer, can be either identical, as in case of TOF-TOF, or different as for examples in 
quadrupole TOF, linear ion trap-orbitrap, etc. [1, 5, 6, 8]. The detector, the last but not the 
least important part of the mass spectrometer, monitors voltage pulses and converts these 
into a signal. This signal represents an ion intensity for a particular m/z and is displayed 
as mass spectra [7]. As the work described in this dissertation was performed on MALDI-
TOF and MALDI-TOF/TOF mass spectrometers, only these instruments will be 
described in further details. 
In the TOF instrument, the m/z is determined from flight times of peptides 
through a tube of specified length under vacuum. This measures the mass of intact 
peptides, which have been generated from intact proteins by enzymatic proteolysis prior 
to analysis. The major difference between the MALDI-TOF (Figure 2D) and MALDI-
TOF/TOF instrument (Figure 2E) is in how the information regarding the amino acid 
sequence (MS/MS) of a specific peptide is generated. In a MALDI-TOF instrument, the 
5 
primary sequence analysis can be obtained by a process called post-source-decay (PSD), 
which is based on metastable fragmentation. PSD can be observed when the reflecting 
electrical field (reflectron) is placed at the end of the flight tube [9]. Upon selection of the 
parental ion [MH]+ for analysis, a MALDI-PSD spectrum is obtained as a stitch of 
manually acquired spectra corresponding to different portions of the peptide under 
investigation (from the parental ion to the immonium ions) in a form of windows. Each 
window (correlates to a part of the spectra) corresponds to gradual changes in reflectron 
voltages [9]. A more common method to induce fragmentation for MS/MS analysis is 
collision-induced dissociation (CID), which is based on multiple collisions between a 
peptide under study with inert gas atoms [10]. The MALDI TOF-TOF instrument 
contains a collision cell between two TOF sections (Figure 2E). Upon selection of the 
parental ion [MH]+ the entire MS/MS spectrum is automatically acquired. 
The MS/MS spectrum of a peptide precursor ion allows the assignment of an 
amino acid sequence. As the amide bond is the lowest energy bond in peptides, this is 
where most of the fragmentations will occur, thus generating y-ions (C-terminal fragment 
ions) and b-ions (N-terminal fragment ions) (Figure 3A) [7]. Additionally, internal 
fragments due to double cleavage of peptide bond may also be observed [7]. 
Mass spectrometry and biological questions 
Biological mass spectrometry mainly focuses on the complex world of proteins. 
This diversity is not only due to the fact that a particular gene can give rise to multiple 
distinct proteins as a result of alternative splicing or that some proteins can differ in a few 
amino acids due to sequence polymorphisms, but it is also a reflection of the vast array of 
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Figure 3. The ABC's of peptide sequencing 
(A) Within the MS-instrument, the bond breakage mainly occurs at the amide bond, the 
lowest energy bond. If the charge is retained by the amino-terminal fragment, b-ions are 
formed and detected; if the charge is retained by the carboxy-terminal fragment, y-ions 
are formed and detected. (B) Derivatization of a peptide by chemically assisted 
fragmentation (CAF). CAF reagent introduces a negatively charged group to the amino-
terminus of tryptic peptides, thus only y-ions will be detected in positive ion mode. 
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glycosylation and ubiquitination just to mention a few. The changes in post-translational 
modifications can be either analyzed conceptually for the entire proteome (proteomics) or 
for a single protein. This will be described later. 
With the advancement of the instrumentation and analysis software, one could 
now answer questions like what proteins are present within the yeast 80S ribosome [11], 
what dynamic changes in the complex composition does the pre-60S ribosome undergo 
[12] and what proteins are residents in which mammalian organelle [13]? These are a just 
few examples of the many proteomics studies reported in the last ten years. One 
limitation of this technology is the under-representation of low abundance proteins. 
Furthermore, as MS-based identifications rely on the detection of peptides, additional 
factors must be considered including that some peptides might be too small or too large to 
be detected, not all peptides are ionized efficiently and some might saturate the detector 
[14]. In order to lessen experimental bias due to the presence and ionization of high 
abundance peptides, a selected reaction monitoring (SRM)-based MS has been recently 
implemented [15-17]. In this experimental approach, the parameters for MS/MS data 
acquisition are pre-set, so that the instrument will only record three to five unique 
proteotypic peptides for each protein, if these correspond to calculated y-ion series under 
two main charge states. Furthermore, in a multiple reaction monitoring (MRM)-based 
MS, multiple peptides can be targeted in a single experiment by repeatedly cycling 
through a list of SRM-ion pairs associated with a set of specific retention times [18]. 
One of the major forces enabling proteomic analyses was the completion of entire 
genome sequences for numerous organisms. These allow comparison between acquired 
MS and MS/MS spectra with theoretically calculated fragment sizes from the in-silico 
digest of a protein sequence in the databases. This is feasible because proteases 
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commonly used to digest proteins into peptide are sequence specific, for example trypsin 
only cleaves C-terminal to lysine and arginine residues. 
However, to date, not all of the organisms have their genomes sequenced and not 
all of the proteins sequences have been deposited into databases. As the annotations of 
MS/MS spectra containing y- and b-ions without prior sequence information are 
challenging, simplifications of the spectra can be achieved by chemical derivatization (so 
called chemically assisted fragmentation, CAF) [19, 20]. This method allowing de novo 
sequencing is based on attachment of sulfonic acid to the N-terminus of each peptide 
(+136 Da), which promotes an efficient charge-site initiated cleavage of peptide amide 
bonds, and thus enables selective detection of a single series of fragment ions, the C-
terminal y-ions (Figure 3B) [19, 20]. A step to protect lysine side chains from sulfo nation 
includes conversion to homoarginine (+42 Da) [20]. 
One of the organisms for which the genome has not been sequenced yet is the 
brine shrimp Artemia franciscana. In collaboration with Dr. A. Warner, Department of 
Biological Sciences, University of Windsor we employed a MS-based approach to 
identify a novel protein from this species. A heat-stable protein was purified from 
encysted A. franciscana embryos and identified from peptide fragments by CAF 
derivatization combined with de novo sequencing. This study will be discussed in detail 
in Chapter 2 of this thesis. 
Biological mass spectrometry and sample complexity 
The complexity of peptide samples can be decreased by an array of separation 
techniques. Peptides generated from proteins digested in solution (the "bottom-up" 
approach, [1] can be fractionated by multidimensional chromatography called MudPIT, 
9 
where the first separation is based on charge (strong cation exchanger) and the second on 
hydrophobicity (reverse-phase) prior to direct injection into the electrospray based MS-
instruments (Figure 4A) [11,21]. 
Alternatively, instead of decreasing complexity of peptide samples by 
chromatographic separation, proteins can be first separated on one-dimensional (ID) or 
two-dimensional (2D) SDS-PAGE prior to enzymatic digestion into peptides. This allows 
identification by either MALDI or ESI-MS (Figure 4B). 
An elegant protocol based on the use of tandem affinity purification (TAP) tags 
allows co-purification of interacting partners at substoichiometric levels [22]. Originally 
this method included an SDS-PAGE separation of the protein components of the 
immunoprecipitated complex and the collection of unique protein bands allowing separate 
proteolytic digests to be performed. Overall, this decreased the complexity of analyzed 
peptide samples [22]. The classical route for identifying interacting partners involves 
over-expression systems, that usually employ genetically engineered fusion proteins 
containing one tag, for example Flag-tag, Myc-tag, etc. These tags allow affinity 
purification and/or detection, when a suitable antibody directed against endogenous 
protein is not available, or not suitable for these applications. However, the ability to 
detect fusion proteins at low concentrations in a complex mixture in these one-tag over-
expression systems is limited. This problem was circumvented by the introduction of two 
different tags (the TAP-tag system) separated by a protease recognition sequence (tev) in 
frame with the protein for which the goal is to identify interacting partners (Figure 4C). 
After expression of this fusion protein, the first purification step is based on the affinity 
between IgG -binding domain (the first tag) and the IgG beads. Upon removal of non-
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Figure 4. Alternative approaches to decrease sample complexity 
(A) Peptide fractionation by the MudPIT, multidimensional chromatography method [11, 21]. 
After enzymatic proteolysis in solution, acidified peptides are first separated on a strong cation 
exchange column (SCX). Then as a discrete fraction of peptides are displaced from this column, 
peptides are further resolved by a reverse phase (RP) chromatography column followed by direct 
injection into the MS-instrument. (B) Proteins are first separated by ID (example shown) or 2D 
SDS-PAGE. The protein of interest is cut out of the gel and subjected to an in-gel digestion to 
generate peptides. (C) Schematic presentation of a TAP-tagged protein [22]. (D) Interacting 
partners of the target protein (depicted in green and red) are identified from non-specific 
contaminating proteins (depicted in grey) after two affinity purification steps. The first step is 
based on affinity of protein A to IgG beads. After removal of unbound proteins, the target protein 
is released upon TEV cleavage. The second step is based on the affinity of the calmodulin binding 
peptide for calmodulin beads in the presence of calcium. This purification step removes traces of 
non-specific contaminating proteins as well as TEV protease. The target protein and its interacting 
partners are collected from the beads upon EGTA elution and identified by MS. 
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cleavage with tev protease. Thus the IgG binding domain remains attached to the beads. 
The second purification step is based on affinity of a calmodulin binding peptide (the 
second tag) to calmodulin beads in a presence of calcium. Upon removal of any carry-
over non-specific proteins and tev protease by washing steps, the over-expressed protein 
and its interacting partners are eluted from the beads in the presence of chelating agents, 
such as EGTA, and then separated by SDS-PAGE (Figure 4D). The protocols described 
so far allow for the identification of proteins as cellular components and members of 
protein-protein interaction networks. However, if the biological questions are rephrased to 
monitor differences in protein abundance or their post-translational modifications under 
various conditions, labelling protocols that allow quantification and direct comparison of 
two different states in the same analysis are required. 
Mass spectrometry as a quantitative tool 
Mass spectrometry is not inherently a quantitative technique due to the fact that 
different molecular species (e.g. different peptide sequences) will have diverse ionization 
efficiencies. Several quantitation methods for MS-based approaches have been devised 
and can be divided into two types, absolute and relative [14]. The general principle 
behind these methods takes advantage of the fact that chemical and physical properties of 
isotopically labelled compounds are identical to their naturally occurring counterparts, 
with the exception of their mass [23, 24]. Thus stable isotopic nuclei (carbon-13, 
nitrogen-15, oxygen-18 and deuterium) will not alter ionization efficiency and can be 
either incorporated into peptides and function as relative references, or included into 
samples as internal standards [25]. 
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The relative labelling can be either accomplished by metabolic incorporation (i.e. stable 
isotope labelling by amino acids in cell culture, SILAC [23]), by post-harvest chemical 
derivatization method (i.e. isotope-coded affinity tag, ICAT, [24], isobaric tags for 
relative and absolute quantification, iTRAQ, [26]), or by incubation with H2180 during 
enzymatic digestion [27]. 
Absolute quantification is based on 'spiking' known quantities of chemically 
synthesized stable isotope labelled peptide as internal standards (absolute quantitation, 
termed AQUA, [28]). The major limitation of the AQUA method is the requirement for 
chemical synthesis of isotope containing peptide equivalents to proteolytic digest of all 
generated peptides, and thus is restricted to a small number of pre-selected proteins [14]. 
With regards to the relative quantification strategies, the least commonly utilized 
approach is based on proteolytic labelling with oxygen-18 during proteolytic digestion. 
As this can result in a 2 or 4 Da shift, due to incorporation of either one or two oxygen-18 
atoms into the carboxyl terminus of each generated peptide, this may complicate the 
quantification. Also, if only one oxygen is replaced it might cause an overlap of isotopic 
envelopes [14, 29], as each MS-detected signal corresponding to a peptide consists of 
isotope cluster of peaks [7]. These peaks are separated by 1 Da, caused by the 1% 
probability in nature of each carbon-12 atom to be a carbon-13 isotope [7]. In addition, 
further complications exist in that variability is added as a result of slow or incomplete 
incorporation of the oxygen-18 for highly acidic peptides [30]. 
Mass spectrometry and isotopic in vivo labelling 
Biologists often ask whether a certain protein is present within a particular 
sample, and if the answer is yes, a typical follow-up question is in what amount. In order 
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to address the quantitative part of their questions, so called "metabolic" or "in vivo" 
labelling methods were developed, which are based on the incorporation of stable 
isotopes containing essential amino acids into each synthesized protein. The original 
proof-of-principle SILAC report used incorporation of an isotopically labelled deuterated 
form of leucine (2H3-Leu) in sample A ('heavy') which was compared to sample B, in 
which cells were grown in a media containing normal leucine (H-Leu, 'light') [23]. After 
experimental treatments (in this case myoblast differentiation), the protein populations 
were harvested and mixed together, separated on SDS-PAGE and proteolytically digested 
(Figure 5A). As the exact ratio between labelled and unlabelled proteins/peptides is not 
affected, quantitation (based on peak intensity) can be performed either on the peptide 
mass or fragment spectrum as the fragmentation patterns are identical and no 
complications are introduced due to label (3 Da difference). The advantages of this 
labelling technique include the ability to label many proteins in a cell (as more than half 
of tryptic peptides contain leucine), there is no difference in labelling efficiencies 
between samples (cells are exposed to isotope containing amino acids for a prolonged 
period of time, five days in culture, prior to treatment), and the labelling is consistent 
among numerous peptides from the same protein and is sequence specific [23]. However, 
problems were encountered upon reverse phase separation of peptides due to both, the 
deuterium label and the fact that not all peptides generated by trypsin digest were 
labelled. In the second generation of labelled amino acids, the stable isotopes were 
carbon-13 and nitrogen-15, and the label was incorporated into lysine and arginine, 
instead of leucine. As trypsin (peptide bond cleavage at arginine and lysine residues) is 
the most commonly used protease in MS-based experiments, when isotopicaly labelled 
lysine (13C615N2-Lys) and arginine (
13C6I5N4-Arg) are incorporated, all detected peptides 
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Figure 5. Quantitative mass spectrometry 
(A) A schematic presentation of the SILAC method, the "metabolic" or "in vivo" labelling 
technique [23]. For sample A, cells are grown in the presence of an isotopically labelled 'heavy' 
amino acid (either Leu, Lys or Arg, or a combination of Lys and Arg) prior to the experiment. 
Thus all proteins are isotopically labelled. For sample B, the cells are grown in normal media and 
thus the proteins will contain 'light' labelled amino acids. One culture is exposed to the desired 
treatment after which cells are lysed and proteins are extracted from both samples, afterwards 
both samples are mixed together and might or might not be subjected to purification protocols 
prior to enzymatic cleavage into peptides. The peptides corresponding to the same protein from 
two different samples have the same properties, with the exception of the isotopic label (and 
subsequently different m/z) thus allowing quantification. This therefore allows the determination 
of the affect of the treatment on protein levels. (B) A schematic representation of the ICAT 
method, one of the "in vitro" labelling techniques [24]. ICAT allows isotopic labelling of cysteine 
residues from numerous samples, including non-living cells and tissues. The first step requires 
denaturation of proteins followed by treatment with reducing agent, thus generating free thiol 
residues susceptible to ICAT derivatization. Then the samples under comparative study are 
combined and subjected to enzymatic proteolysis. The labelled peptides are purified by cation 
exchange and avidin affinity columns. After biotin cleavage, quantification of purified cysteine 
containing peptides is performed by MS. 
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are labelled with an 8 Da mass shift difference for Lys and a 10 Da for Arg containing 
peptides [31]. 
An alternative approach to the TAP-tag system for identification of protein-
protein interactions involves the use of untagged endogenous proteins, at their normal 
cellular levels, in a quantitative immunoprecipitation combined with a knockdown screen 
[32]. This method, QUICK is a hybrid of SILAC, RNA interference (RNAi) and 
coimmunoprecipitation [32]. As RNAi allows specific depletion of a protein, its 
interacting partners can be identified upon immunoprecipitation with endogenous 
antibody, elution, digestion and MS-based comparison of peptide ratios between 'light' 
cells, where the protein under study has been down-regulated and non-treated 'heavy' 
cells. After the immunoprecipitation and digestion, MS-analysis detects peptides at a 
higher intensity corresponding to the protein under study and its interacting partners in 
the 'heavy' labelled sample (non-treated), as these are decreased or absent from RNAi 
treated cells; whereas peptides corresponding to contaminating proteins are observed at 
similar levels [32]. 
Another promising adaptation of SILAC is in a screen for identification of novel 
DNA-protein interactions [33]. Protein levels are often a reflection of the regulation of 
transcription as the case of the presence/absence of specific transcription factors 
recognition sites within promoter regions (upstream of transcription start site). DNA 
methylation also affects transcript levels. For example, in mammals in approximately 
80% of all genes the promoter regions contain stretches of cytosine-guanine (CG) 
nucleotides, so called CpG islands [34]. The cytosine within CpG dinucleotides is 
susceptible to methylation, an event that potentially may disrupt the ability of a 
transcription factor to bind their recognition sequence. CpG island methylation within 
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promoter regions of numerous genes have also been shown to display tissue specific 
patterns as well as a correlation with many malignancies [34]. In order to identify 
signalling networks mis-regulated due to methylation of a specific CpG island, 
biotinylated double stranded synthetic oligonucleotide containing either fully methylated 
cytosine residues within a CpG island or a corresponding non-methylated sequence were 
separately immobilized onto streptavidin beads [33]. Affinity chromatography was 
performed separately for DNA containing the methylated CpG island and 'heavy' (2H4-
Lys) labelled nuclear extract and for DNA containing the non-methylated CpG island and 
'light' labelled (H-Lys) nuclear extract. Afterwards samples are combined and DNA-
protein complexes were eluted by restriction enzyme digestion, as the nucleotides were 
engineered to contain endonuclease recognition site. Thereafter protein complexes are 
either immediately digested with a protease in-solution or proteins can be first separated 
on SDS-PAGE and then in-gel digested. Lysine containing tryptic peptides originating 
from DNA methylation specific interacting proteins were detected at a higher peak 
intensity for the 2H4-form (mass shift difference of 4 Da), while DNA affinity purified 
non-specific proteins displayed 1:1 ratio between isotopic forms [33]. 
Mass spectrometry and non-isotopic quantitation 
In the case where samples have not been or cannot be isotopically labelled, 
approaches for label-free quantitative proteomic have been developed. These methods 
allow for extraction of quantitative data from mass spectra, and require implementation of 
computational algorithms. One of the label-free quantitative methods is based on 
normalization of the number of observed peptides to the number of observable peptides 
for the protein under study, the so-called protein abundance index (PAI) [35, 36]. This 
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was later modified to exponentially modified PAI (emPIA) method, as it was observed, 
that the number of peptides observed has a logarithmic relationship to the amount of 
protein within that sample [37]. Furthermore, this method was recently further enhanced 
by the inclusion of correction factors that allow the measurement of absolute protein 
concentration per cell from the proportionality between protein abundance and the 
number of observed peptides [38]. The second label-free quantitative method is only 
applicable in highly reproducible liquid-chromatography interfaced MS-instruments. This 
method is based on extracted ion current, which is the area under the curve, when signal 
intensity as peptide elutes from chromatographic column, is plotted versus time [39]. The 
extracted ion current is linearly related to the amount of particular peptide (extracted ion 
currents for different peptides of the same protein are very different) under the same 
experimental conditions [14]. Samples under comparative analysis are processed and 
analyzed separately, one after another. It is noted that slight changes in sample processing 
or the presence of contaminants, such detergents, interfere with quantification [14]. 
Applications of this label-free quantitative analysis include, but are not limited to, protein 
correlation profiling, an adaptation to provide protein abundance profiles upon 
fractionation procedures [40] and detection of changes in the cell surface proteome [41]. 
Mass spectrometry and isotopic in vitro labelling 
A second category of isotopic labelling strategies is based on chemically targeting 
reactive groups on side chains of amino acids or peptide termini. Some of these labelling 
approaches are performed at the peptide level and some at the protein level, depending 
upon the experimental questions. As the above-described in vivo labelling techniques are 
limited to cells that can be cultured in appropriate media, the alternative approaches for 
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incorporation of labels allowing quantitative proteome analysis can be performed on a 
wide variety of samples, including patient specimens. 
The most popular of the isobaric mass tags, iTRAQ allows concurrent analysis of 
up to eight different samples and consists of an amine-specific reactive group, a reporter 
mass group (variable mass of 114-117 Da (for 4-plex assays) or 113-121 Da (for 8-plex 
assays)) and a balancer group (variable mass of 191-188 Da or 192-184 Da) [26]. The 
iTRAQ label introduces a highly basic group at the N-terminus of peptides and lysine side 
chains, and during MS/MS the reporter groups are released as singly charged ions of 
masses at 114, 115, 116 and 117 m/z (in a 4-plex experiment) thus allowing 
quantification based on their ratios. 
Recently introduced (by Applied Biosystems) the non-isobaric, amine based 
isotope-coded reagent, mTRAQ, allows concurrent quantification of three samples, as 
addition of 13C and 15N containing tags as precursors that result in a mass shift of 0, 4 and 
8 Da for arginine and 0, 8 and 16 Da for lysine tryptic peptides [29]. 
Another class of labelling reagents has specificity towards sulfhydryl groups, a 
reduced form of the side-chain in cysteine residues. These isotope-coded affinity tags 
(ICAT) contain a thiol-specific reactive group (iodoacetamide) and a biotin affinity tag, 
separated by an isotopically coded linker [24]. This quantitative labelling technique was 
designed in order to simplify the complex peptide pool prior to MS-analysis, while 
maintaining high proteome coverage. Cysteine was chosen because it is a rare, but 
functionally essential amino acid, with most proteins containing at least one cysteine. 
This fact reduces the complexity of the peptide sample by approximately an order of 
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magnitude (Figure 5B) [24]. The major caveat of this method is that the representation of 
proteins that lack cysteine residue is compromised. Based on current estimates this 
represents approximately 5% of human proteins [42]. In the first generation of ICAT 
reagents the difference between 'light' and 'heavy' was 8 Da, due to incorporation of 
eight deuterium atoms into the 'heavy' tag [24]. There were a few shortcomings related to 
the design of these labelling tags, such as a shift in the elution of corresponding peptides 
from reverse phase chromatography due to deuterium modification and ambiguities in 
assigning peptides with more than one cysteine. Note, a difference of 16 Da may 
represent the presence of either two labelled cysteine residues or oxidation of methionine. 
An additional difficulty was the possibility of undesired fragmentation at the biotin tag, 
instead of fragmentation at the peptide backbone during MS/MS. This led to development 
of a second generation of ICAT reagents [43], which are now commercially available. 
These ICAT reagents include an acid-cleavable linker group between the biotin moiety 
and sulfhydryl reactive isotope tag, while the 'heavy' reagent contains nine 13C atoms 
instead of eight deuterium atoms [43, 44]. These reagents allow the comparison of the 
content and relative abundance between two samples, by first reducing the side chains of 
cysteinyl residues in a sample representing one cell state followed by derivatization with 
Tight' ICAT reagent. In the second sample, equivalent groups are first reduced and then 
derivatized with 'heavy' ICAT reagent [24]. After labelling, the two samples were 
combined and proteolytically digested; thereafter the resulting peptides were separated by 
multidimensional chromatography, including isolation of tagged peptides by avidin-
affinity. Quantification is based on comparison of the relative signal intensities (ratios) 
between peptide ions pairs of identical sequence, with a mass difference due to 
incorporation of 'light' and 'heavy' ICAT tags which are chemically identical, thus 
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allowing an accurate measure of the relative abundance of the peptide (hence the protein) 
[24]. The application of ICAT-labelling to study changes in protein abundance at the 
entire proteome level ranges from analysis of differences in microsomal fractions 
between naive and differentiated human myeloid leukemia cells [45], in tracheal tissue of 
cystic fibrosis patients [43], and serum of hepatocellular carcinoma patients [46], just to 
mention a few from a long list. 
The thiol group of cysteine residue is very susceptible to oxidation by reactive 
oxygen species or reactive nitrogen species [47]. Furthermore, thiol groups (-SH) are 
essential for the function of many proteins, in that oxidation (in a form of disulfide, -S-S) 
may increase or decrease a protein's activity, thus affecting their function. ICAT reagents 
have provided an invaluable tool to identify which cysteines are susceptible to oxidation 
(for example after exposure to hydrogen peroxide) and for the quantification of the 
amount of oxidized cysteine residues [48, 49]. This procedure is based on the premise that 
oxidized cysteine residues are not susceptible to ICAT derivatization, when samples are 
labelled under non-reducing conditions. Thus normal sample would be labelled with 
Tight' ICAT reagent, and the experimental sample exposed to oxidant stress, would be 
labelled with 'heavy' ICAT reagent, thus the decrease in specific labelling of oxidant-
sensitive cysteine thiols can be quantified from the ratio of ICAT reagents. 
One of key redox modulators that contain a CysXXCys motif within two active 
sites is protein disulfide isomerase (PDI). In collaboration with Dr. B. Mutus, Department 
of Chemistry and Biochemistry, University of Windsor, ICAT labelling was utilized to 
identify and quantitate redox sensitive cysteines on PDI after auto-oxidation. This study is 
presented in detail in Chapter 3. 
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In addition to identification of redox-sensitive thiols, the ICAT in combination 
with labelling has been adapted to trap differential thiols, in a method called OxICAT 
[50]. The OxICAT method is based on sequential labelling of the same sample; first free 
thiols are labelled with Tight' ICAT reagent after protein(s) denaturation and afterwards 
disulfides are disrupted by strong reducing agent, thus allowing for these thiols to be 
labelled with 'heavy' ICAT reagent. Cysteines that were originally present as thiols, will 
be detected only as Tight' ICAT labelled; whereas cysteines which were originally 
oxidized, will be identified by the 'heavy' ICAT modification. This will result in a 9 Da 
shift if the peptide contains one cysteine and if more cysteines, multiples thereof. If 
cysteines are at redox equilibrium, then both forms (Tight' and 'heavy' ICAT labelled) 
for the same peptide would be detected. This approach also provides a novel method to 
monitor the kinetics of thiol oxidation by trapping oxidation intermediates within a 
purified protein (for example upon oxidative stress, thus activating or inactivating the 
protein) [50]. 
Thiols can also be modified by either S-nitrosylation or S-glutathiolation [51]. The 
MS-based approach to identify Cys-SNO modifications, SNO-Site Identification method 
SNOSID, is essentially an adaptation of biotin-switch assay [52, 53]. First, all free thiols 
in the protein mixture are methylated, then Cys-SNO are selectively reduced (by 
ascorbate), thus generating a new unmodified thiols, at which position biotin will be 
attached through a disulfide bond (upon addition of N-[6-(biotinamido)hexyl]-3'-(2'-
pyridyldithio)propionamide, biotin-HPDP). At this time, proteins are proteolytically 
digested, biotin-tagged peptides are isolated by avidin-affinity, and subsequently released 
by the reduction of the disulfide linker. As this last described method is not based on 
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ICAT technology, it serves as an example that alternative methods are available to study 
cysteine modifications. 
Mass spectrometry andpost-translational modifications 
So far, MS-based approaches designed to identify novel proteins and quantitative 
differences among samples have been described. Nevertheless, biological functions of 
most proteins are regulated through post-translational modifications. The ability to 
unambiguously identify these post-secondary modifications (and their location), further 
highlights the power of MS. Identification is achieved from MS/MS spectra analysis, as 
the observed fragmentation pattern is altered due to the mass shift introduced by the 
modification. The acquired spectra can be compared to a predicted fragmentation pattern 
(generated by open-source software) including defined modifications introduced at a 
specific amino acid. For example, acetylation on lysine residue introduces a mass shift 
difference of +42 Da of the parent ion [MH]+ compared to unmodified peptide in MS 
spectra (prior to fragmentation), while the position of modified lysine can be assigned by 
+42 Da shift detected in MS/MS spectra at the position of this residue. In the case of 
methylation, the extent of mass shifts introduces depends on the number of methyl groups 
present, i.e. +14 Da for methylation, +28 Da for dimethylation and +42 Da for 
trimethylation. Ubiquitination plays an important role in protein stability, as ubiquitinated 
proteins are targeted for degradation [54]. The MS-identification of lysine residues 
originally modified by ubiquitination is based on detection of ubiquitin remnants, in a 
form of a covalently attached glycine-glycine dipeptide, the signature peptide (mass shift 
difference at the lysine residue of 114.1 Da), after trypsin proteolysis; sustained by 
trypsin missed cleavage at this lysine residue (proteolysis does not occur at modified 
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lysines) [55]. Protein modifications by carbohydrates (O-linked and N-linked 
glycosylation) have been increasingly recognized as biochemical alterations associated 
with malignant transformations and tumorigenesis [56]. Due to the incredible variability 
in the glycan structures, and complexity of these modifications, methodologies applied to 
their identification and characterization are beyond the scope of this overview. 
Mass spectrometry and identification of phosphorylation sites 
Last, but not least, phosphorylation is one of the most important regulatory 
modifications, affecting a broad range of biological functions and processes. 
Phosphorylation occurs most commonly on serine residues (86.4%), followed by 
threonine residues (11.8%) and rarely on tyrosine residues (1.8%) (values are based on in 
vivo phosphoproteome analysis) [57]. Other amino acids that can be phosphorylated are 
histidine and glutamic acid [42]. Phosphorylation is detected as a modification of the 
peptide by a +80 Da shift in the MS spectra in comparison to the non-phosphorylated 
peptide and typical dominant -98 Da and -80 Da fragments detected in the MS/MS 
spectra due to neutral losses (the mass of H3PO4, and HPO3 respectively, derived from 
phosphoserine and phoshothreonine). In the case of phosphotyrosine, a specific 
immonium ion (an internal fragment containing just a single side chain of an amino acid) 
is detected at 216.02 m/z [58]. 
Due to the dynamic nature of phosphorylation, phosphorylated proteins are often 
present at low levels, thus the fraction of phosphorylated peptides will be at a much lower 
concentration compared to their non-phosphorylated counter-parts (high abundance 
peptides cause ion suppression during ionization process) [59]. In addition to low 
stoichiometry, phosphopeptides also suffer from low ionization efficiency [59]. These 
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problems can be circumvented by techniques that promote enrichment of 
phosphopeptides. 
Originally, three methods were described for the identification of phosphopeptides 
from a complex protein mixture. The first one included replacement of phosphate groups 
by ethanedithiol, followed by the addition of a biotin tag, the latter allowing 
phosphopeptide affinity purification [60]. A limitation of this method includes 
complications that arise during the derivatization process and the inability to detect 
phosphotyrosine residues, as only phosphoserine and phosphothreonine undergo (3-
elimination [61]. The second method was based on a chemistry intensive six-step 
derivatization/purification protocol for tryptic peptides, where the capture of 
phosphopeptides was accomplished through a reversible covalent linkage to a solid 
support [62]. The third method employs phosphopeptide enrichment from whole cell 
lysates by immobilized metal affinity chromatography (IMAC) on peptides derivatized by 
esterification of carboxylate groups [63]. IMAC has become one of the most commonly 
used strategies for phosphopeptide enrichment [5] and will be described in further details 
later. 
In addition to IMAC, numerous techniques have recently been developed to enrich 
for phosphopeptides. For example, strong cation exchange chromatography (SCX-based 
strategy), which separates peptides according to ionic charge, allows enrichment of 
tryptic phosphopeptides from unmodified peptides (singly charged species elute before 
multiply charges ones) [64]. At low pH (2.7) only lysine, arginine, histidine and the 
amino terminus are charged with a net charge state of+2 on non-phosphorylated peptide, 
while phosphate groups maintain a negative charge with a net charge state of+1 on a 
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phosphopeptide [64]. The major caveats of this enrichment technique include the fact that 
it is limited to studying trypsin generated proteolytic fragments as well as having an 
inability to detect phosphopeptides containing a single histidine residue [65]. The 
presence of histidine within a phosphopeptide alters the net charge to +2, the same as 
non-phosphopeptides, thus effecting the elution properties of this phosphopeptide from 
the SCX-column and hindering detection [65]. Nevertheless, this phospho-enrichment 
protocol is powerful and has allowed the phosphoproteomic analysis of the developing 
mouse brain [65]. Furthermore, in combination with other phosphopeptide enrichment 
methods, SCX-based strategies have been implemented as the first fractionation step in 
numerous studies, including the effect of epidermal growth factor induced simulation in 
HeLa cells [57], profiling of mitotic phosphorylation [66] and analyses of the 
phosphoproteome in mouse liver [67], and Drosophila melanogaster embryos [68]. 
A motif-specific phosphopeptide enrichment method has also been described that 
is useful for characterizing specific kinase targets. The method is based on the 
precipitation of phosphopeptides with Ba2+ in the presence of acetone under varying pH 
[69]. For example, Ba2+-based precipitation in combination with pH dependent 
fractionation and MudPIT separation of peptides was used to analyze nuclear extracts 
from HeLa cells. When the identified phosphopeptides were analyzed in a pH dependent 
manner, at pH 3.5, 86% of the phosphopeptides were unique and the sequence adjacent to 
the phosphorylated residue contained acidic amino acids; at pH 4.6 70% and at pH 8.0 
56% of the phosphopeptides were unique. Ba2+-based precipitation at pH 4.6 and 8.0 
displayed an increased preference for proline residues C-terminal to the phosphorylation 
site. Overall, the pattern of Ba2+ precipitation of phosphopeptides at each pH coincided 
with consensus sequences for specific kinases [69]. 
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As phosphorylation at tyrosine residue ranges between 0.05%> (as determined by 
phosphoamino acid analysis [70]) to 1.8% (as determined by phosphoproteome analysis 
[57]) of the total cellular phosphorylation, selective enrichment for phosphotyrosines 
containing phosphopeptides is necessary when the quest is to identify tyrosine 
phosphorylation sites. The method of choice to selectively enrich for these 
phosphopeptides is based on peptide affinity purification with an anti-phosphotyrosine 
antibody. The immuno-affinity phosphopeptide strategy was first applied to profile 
analysis of oncogenic Src (tyrosine kinase) down-stream targets and comparative analysis 
of two cancer cell lines derived from anaplastic large cell lymphomas [71]. The same 
experimental approach was utilized to study the phosphotyrosine proteome in mouse 
brain [72]. 
In addition to IMAC, a metal oxide affinity chromatography (MOAC) based 
method, which utilizes Zr02 and Ti02, has been shown to selectively bind 
phosphopeptides [73-75]. The limitation of this enrichment method is similar to IMAC 
(discussed below), i.e. the possibility of retention of acidic non-phosphopeptides [74, 75]. 
When a phosphopeptide standard mixture was isotopically labelled with iTRAQ (to allow 
direct comparison) and phosphopeptides were enriched by either Ti02 or Fe3+-based 
affinity and then mixed together prior to MS-analysis, comparable performance between 
these two technique was observed [58]. Furthermore, when phosphopeptides from 
biological sample were SILAC labelled (to quantitate changes in phosphorylation after 
EGF stimulation), phosphotyrosine containing proteins were immuno-precipitated with an 
anti-phosphotyrosine antibody, protein complexes were separated on a gel and after in-gel 
digestion, peptides were enriched by either Ti02 or Fe3, results were similar [58]. 
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Immobilized metal ions, such as Fe and Al bind phosphoproteins and 
phosphopeptides with high specificity [76, 77]. Furthermore, after enrichment of 
phosphopeptides on either Fe3+ and Ga3+ loaded agarose, phosphorylated residues can be 
identified by MS [78]. This experimental protocol is the basis of commercially available 
PHOS-Select resin (from Sigma-Aldrich). The major limitations of this enrichment 
technique include binding of non-specific peptides and variability in the retention of 
phosphopeptides [63, 79]. IMAC enrichment of phosphopeptides has been employed to 
identify human mitotic spindle phosphoproteins [80], in the phosphoproteome analysis of 
a-factor arrested Saccharomyces cerevisiae [81] and phosphoproteins in 
Schizosaccharomyces pombe [82]. 
Mass spectrometry and dual specificity phosphatases 
Dual specificity phosphatases (DUSPs) are able to remove a phosphate group 
from phosphoserine, phosphothreonine and phosphotyrosine residues [83, 84]. This very 
heterogenous sub-group is a subfamily of the protein tyrosine phosphatase (PTP) 
superfamily [83]. All PTP family members (including DUSPs) contain the invariant 
catalytic sequence C(X)sR and the hydrolysis of phosphorylated substrate involves 
formation of a stable phosphoryl-intermediate [85, 86]. The DUSPs are the most diverse 
group in terms of substrate specificity, and include the following families; MKPs 
(mitogen-activated protein kinase phosphatases), Slingshots, PRLs (phosphatase of 
regenerating liver), Cdcl4s, PTENs (phosphatase and tensin homologue deleted on 
chromosome 10), MTMRs (myotubularins) and the atypical DUSPs [83, 84]. 
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The atypical DUSPs, a group of 16 members, are generally small, under 250 
amino acids, and lack specific mitogen activated protein kinase (MAPK) targeting motifs 
even through a few family members can dephosphorylate at least one of the MAPKs 
(either Erk, Jnk or p38). These includes DUSP3 (VHR) [87], DUSP14 [88], DUSP18 
[89], DUSP19 [90], DUSP22 [91], DUSP23 [92] and DUSP26 [93]. Other members 
display a broad range of substrate specificities. For example, laforin dephosphorylates 
complex carbohydrates [94] and DUSP11 interacts with RNA [95]. If all of this 
heterogeneity and variability within this sub-class of DUSPs is taken into consideration, 
we can expect that hYVHl (also known as DUSP 12), the DUSP of interest in the 
Vacratsis lab and the only atypical DUSP that contains a zinc-binding domain, to have a 
unique role. 
YVH1 orthologues are extremely conserved throughout evolution; present in 
species as diverse as Plasmodium falciparum [96] to humans signifying YVH1 
orthologues as regulators of conserved cellular functions. Interestingly, YVH1 
orthologues are present as single gene copies even in advanced mammals such as humans, 
suggesting that there has been evolutionary pressure against yvhl gene duplication or 
deletion. 
Recent projects from our laboratory have used several MS-based approaches to 
discover novel hYVHl functions. A MS-based approach was utilized to identify the 
cytoprotective heat shock protein 70 (Hsp70) as the first known hYVHl interacting 
protein [97]. Phosphatase assays showed that hYVHl is a heat stable enzyme whose 
activity during oxidative conditions can be modestly increased in the presence of Hsp70. 
Furthermore, this result led to the discovery that hYVHl is a novel cell survival 
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phosphatase and can prevent both thermal and oxidative stress induced cell death. This 
cytoprotective property requires catalytic competence and the zinc binding domain [97]. 
Our laboratory also used differential thiol labelling and MS to reveal that the 
cysteines in the zinc binding domain serve a redox buffer role, allowing hYVHl to 
function under oxidative conditions known to inactivate cysteine based phosphatases 
[98]. In the present study, outlined in Chapter 4, a MS-based approach was also utilized to 
identify phosphorylation sites within hYVHl. Not only are these the first phosphorylation 
sites reported for any YVH1 orthologues, but this result led us to discover that hYVHl 
expression affects cell cycle progression. 
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Objectives of this Thesis 
Recent developments in the mass spectrometry field have facilitated the 
applicability of this experimental tool to study a variety of biological questions. These 
include, but are not limited to, identification of proteins or post-translational 
modifications, and quantitative analysis of proteins after modification of peptides with 
isotopically labelled tags. This dissertation is comprised of three research chapters that 
examine various applications of MS-based methods to study biological questions. 
Chapter 2 investigates the identity of a 21 kDa protein from encysted embryos of 
brine shrimp Artemia franciscana as a group 1 Late embryogenesis abundant protein by a 
MS-based de novo sequencing approach. 
Chapter 3 examines the redox status of cysteine residues within recombinant 
human protein disulfide isomerase after auto-oxidation conditions employing the isotope-
coded affinity tag (ICAT) technology and mass spectrometry. 
Chapter 4 identifies three in vivo phosphorylation sites on hYVHl using a 
combination of a phosphopeptide enrichment protocol and mass spectrometry. This study 
also examines the effect of overexpressing hYVHl and phosphospecific mutants on 
hYVHl localization and progression through the cell cycle. In addition, phenotypes 
observed due to down-regulation of hYVHl with siRNA are also described. 
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CHAPTER 2 
Identification of group 1 LEA protein from A. franciscana by de novo MS 
This chapter incorporates the outcome of joint research undertaken in collaboration with 
Michelle A. Sharon under the supervision of Dr. Alden H. Warner, Department of 
Biological Sciences. The collaboration is covered in Chapter 2 of the thesis. In all cases, 
the key ideas, primary contributions, experimental designs, data analysis and 
interpretation, were performed by the authors; Michelle purified a 21 kDa protein from 
Artemia franciscana, PCR amplified cDNA from an embryonic library corresponding to 
its gene and performed the initial characterization of this protein. My contribution to this 
manuscript was the de novo identification of this protein using mass spectrometry (MS). 
Since the genome of this organism has not yet been sequenced, this included in silico 
analysis for the identification. Based on the peptide sequence corresponding to a 
conserved motif, the 21 kDa protein was identified as a member of group 1 Late 
embryogenesis abundant (LEA) family. Once Michelle completed the gene amplification, 
I was able to match the peptide sequences generated by MS and thus further confirm the 
identity of the 21 kDa protein. 
The results were published: Sharon, M.A., Kozarova, A., Clegg, J.S., Vacratsis, P.O., and 
Warner, A.H. (2009). Characterization of a group 1 late embryogenesis abundant protein 




The brine shrimp, Artemia franciscana is a primitive crustacean, able to survive 
under very harsh hypersaline conditions with their embryos among the most resistant 
multicellular eukaryotes to environmental stress [1]. Encysted embryos can survive 
severe desiccation, anoxia, extremes in temperature, and various forms of radiation [1]. 
Under conditions of stress Artemia embryos, which are encysted, undergo a reversible 
state of dormancy termed diapause that involves both, developmental and metabolic 
arrest. Previously identified proteins restricted to diapause include p26, a member of the 
small heat shock-a-crystallin family [2, 3] and artemin, a heat-stable RNA binding 
protein [4]. However, neither of these proteins has been directly implicated in the ability 
of these embryos to undergo virtually complete water-loss, thus implying the involvement 
of another protein(s) in addition to the known function of carbohydrates. 
Late embryogenesis abundant proteins (LEA), a group of hydrophilic proteins, 
have been proposed to protect cellular and molecular structures from low temperature and 
desiccation-induced damage [5, 6]. Originally identified only in plants, expression of 
these proteins is pre-programmed during the later stages of seed development. However, 
they can also be induced by environmental stress, including desiccation, cold and osmotic 
shock [7]. LEA proteins have been categorized into 6 groups based on their primary 
amino acid sequence and expression patterns. Group 1-3 LEA proteins are characterized 
by the presence of specific sequence motifs. The group 1 LEA proteins contain a 20 
hydrophilic amino acid motif. The group 2 LEA proteins exhibit at least two of three 
distinct sequence motifs (termed the Y-, S- and K-segments). The group 3 LEA family 
members contain multiple copies of an 11 amino acid motif [7]. Categorization within 
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group 4-7 LEA proteins (with exception of Group 5, that contains hydrophobic or atypical 
LEA proteins) remains under discussion [7], despite the fact that several distinctive 
highly conserved motifs have been described [8]. 
In addition to plants, LEA proteins have also been described in animal species 
including the nematode Caenorhabditis elegans [9]. C. elegans is able to enter into a 
reversible state of dormancy during development, the so called dauer juvenile larval 
stage, when the food supply is limited. While in the dauer form, these worms exhibit 
increased tolerance to desiccation and express group 3 LEA-like proteins (Ce-lea-T), 
while the adults are desiccation sensitive [9]. 
The most complex metazoan for which group 3 LEA proteins have been described 
thus far is A. franciscana [8]. AfrLEA 1 and AfrLEA 2 were identified by a differential 
developmental stage specific cDNA library screen [10]. 
In addition, a proteomic study identified LEA proteins in multiple spots on 2D-gels 
belonging to two families; one with a sequence homology to group 3 LEA protein in C. 
elegans and the others with similarities to AtEml in plants [11]. 
As A. franciscana is a model organism for the study of adaptation mechanisms to 
extreme environmental conditions, in a quest to identify proteins that enable the 
dehydration tolerance of the encysted embryos, an analysis of heat-stable proteins was 
performed. Interestingly, a unique protein with an apparent mass of 21 kDa (p21) was 
prominent among the heat-stable proteins. Since to date Artemia's genome has not been 
sequenced, we utilized de novo mass spectrometry to identify a peptide fragment 
corresponding to p21. Furthermore, using MALDI-TOF we generated an amino acid 
sequence for the peptide that enabled the design of DNA oligonucleotides, which in turn 
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allowed the amplification of this gene from an Artemia embryonic cDNA library. This is 
the first report describing identification of a group 1 LEA protein from an animal species. 
Materials and Methods 
Dr. A. H. Warner and members of his research group provided an SDS-PAGE gel 
containing heat-stable protein p21 purified from A. franciscana encysted embryos. Details 
related to the purification protocol, MS-identification (described in detail below), PCR 
based amplification and DNA sequencing; as well as characterization of group 1 LEA 
protein (p21) were published by Sharon et al. [12]. 
De novo protein sequencing by MALDI-PSD 
Following electrophoretic separation by SDS-PAGE and visualization by 
coomassie blue, the band corresponding to p21 was excised. Prior to in-gel proteolytic 
digestion, the gel piece was destained (50%> acetonitrile, 50%> 50 mM ammonium 
bicarbonate) for 1 hr at 37° C, dehydrated in 100%) acetonitrile and excess liquid was 
removed in a speed vac. Thereafter, the gel piece was rehydrated in digestion buffer (50 
mM ammonium bicarbonate) and digested with 200 ng of trypsin (Promega) for 12 hr at 
37° C. Peptides were extracted (60% acetonitrile, 0.1%) trifluoroacetic acid) and desalted 
using micro-Ci8 Zip Tips (Millipore). A portion of extracted peptides was subjected to 
chemically assisted fragmentation (CAF) modification in order to enhance the production 
of y-ions using the CAF Sequencing Kit according to manufacturer's instructions 
(Amersham Bio sciences). Modified peptides were mixed at a ratio of 1:1 with matrix 
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solution (10 mg/mL a-cyano-4-hydroxycinnamic acid in 60%> acetonitrile, 0.1%> 
trifluoroacetic acid) on the target plate. Peptide mass fingerprints were obtained by 
matrix-assisted laser desorption-ionization-time of flight (MALDI TOF) in a reflector 
mode on a MALDI-TOF DE-Pro instrument (Applied Biosystems) using an accelerating 
voltage of 20,000V. MS spectra were internally calibrated using trypsin autolysis peptide 
masses. MS spectra were processed by use of the Data Explorer software (Version 4.0, 
Applied Biosystems) with a S/N threshold of 30 to detect peaks. Selected parent ions 
were subjected to post-source decay analysis using 11 segments stitched together by the 
Data Explorer software (Version 4.0, Applied Biosystems). Post-source decay spectra 
were calibrated with angiotensin I ([MH]+ 1296.69) fragment ion masses. Owing to the 
lack of genomic sequences available for A. franciscana, de novo sequencing 
interpretation of the CAF-post source decay spectra was performed manually. A fragment 
mass tolerance of 0.3 Da was used to assign amino acid sequences. Peptide sequences 
were then searched against the NCBI non-redundant database using the NCBI BLAST 
program (version 2.2.14, www.ncbi.nlm.nih.gov/BLAST). 
De novo protein sequencing by MALDI-MS/MS 
In order to increase sequence coverage, an "in-gel" digestion of p21 was 
performed with either trypsin (Promega) (as described above) or 1 jag of endoproteinase 
GluC (Roche) for 12 hr at 25° C. Upon extraction, peptides were analysed on a 4800 
MALDI TOF/TOF Analyzer (Applied Biosystems) operated in the positive ion reflectron 
mode. The MS data were internally calibrated using autolysis peaks of trypsin or GluC. 
Precursor ions with an S/N ratio of 30 were selected for tandem MS (MS/MS). All 
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MS/MS spectra were calibrated using MS/MS fragment masses from angiotensin I 
([MH]+ 1296.69). MS and MS/MS data were processed using the Data Explorer software 
(Version 4.5, Applied Biosystems). De novo sequencing was performed manually using a 
mass error of 0.2 Da between fragment ion masses to assign amino acid sequences. Once 
the DNA sequencing experiments were complete, the deduced protein sequence (entered 
into NCBI database under accession number EF656614) was used to corroborate MS 
data. 
Results 
Enrichment of a unique 21 kDa heat-stable cytoplasmic protein from A. 
franciscana dormant encysted embryos was initially observed after separation on SDS-
PAGE. In order to identify this protein and obtain sequence information for cloning 
purposes, a MS-based approach was employed. The peptide fingerprint generated from 
trypsin digest, as well as the PSD-spectra acquired for a few peptides did not yield any 
useful matches when analysed against the publicly available databases (including NCBI 
ESTs). As a result of this and since the complete genome sequence of A. franciscana is 
not available, de novo sequencing was necessary in order to assign identity to the 21 kDa 
protein. Derivatization of the tryptic peptides by the CAF reagent (chemically assisted 
fragmentation) greatly simplified the interpretation of MS/MS spectra, as only y-ion 
series were detected, thus enabling amino acid assignment [13, 14]. The amino acid 
sequence of the CAF-modified peptide at [MH+] 1711 m/z was deduced as the following 
sequence: AE(K/Q)(I/L)GHEGYVEMGR (Figure 1A). A search of the NCBI database 
using the BLAST algorithm indicated that this 14 amino acid peptide showed significant 
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Figure 1. Analysis of the 21 kDa protein by matrix-assisted laser desorption-
ionization (MALDI)-tandem mass spectrometry and de novo sequencing 
(A) MALDI-post-source decay spectrum of chemically assisted fragmentation-modified 
tryptic peptide at m/z 1711.9. The y ion fragment ion series in annotated along with the 
loss of sulfonate group. (B) Tandem mass spectrometry spectrum of a tryptic peptide at 
m/z 1584.0 generated by a MALDI TOF/TOF instrument. The detected y and b ion 
fragment masses are annotated. For the deduced sequences, small font indicated the 
inability to differentiate between glutamine and lysine, or isoleucine and leucine. 
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similarity to the LEA family of proteins. Furthermore, this sequence was 71% identical to 
the group 1 LEA protein consensus sequence, thus far only described in few non-plant 
species [7, 8]. It is worth mentioning that the group 1 LEA protein sequence motif 
GGQTRREQLGEEGYSQMGRK is commonly present in several copies, ranging from 
up to four in plants and up to eight in other organisms [8]. The sequence of the CAF-
modified peptide was used to design the original set of PCR primers for amplification of 
this gene from an embryonic cDNA library. The presence of repetitive sequence provided 
challenges during cloning efforts, as well as complicated assignments of unmodified 
MS/MS spectra. Fortunately, we detected a peptide ([MH+] 1584.0 m/z) which was not a 
part of the repeating motif and were thus able to manually assign the amino acid sequence 
to (K/Q)(K/Q)MSRADYAAMG(K/Q)K (Figure IB). It is noteworthy to mention, that 
this peptide was only detected in the unmodified trypsin digested sample, therefore the 
acquired spectra contained both, b- and y-ion fragment series, thereby further increasing 
the complexity of this assignment. The amino acid sequence of this peptide was used to 
design oligonucleotide primers to obtain the entire gene encoding the 21 kDa protein, 
including the C-terminal end. 
Upon successful completion of the PCR-based amplification of the DNA sequence 
for group 1 LEA protein, the deduced sequence was used to obtain higher sequence 
coverage from the generated tryptic peptides (Figure 2). Overall, six peptides were 
subjected to MS/MS analysis, while four ([MH+] 1546.8 m/z, 1668.8 m/z, 1675.8 m/z and 
1704.8 m/z) of them corresponded to the originally identified CAF-modified peptide with 
variability in one to two amino acids. Therefore, these peptides represent the 
characteristic repeats found in group 1 LEA proteins. The fifth peptide ([MH+] 1860.9 
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Figure 2. Analysis of trysin generated peptides from the 21 kDa protein by matrix-assisted 
laser desorption-ionization (MALDI)-tandem mass spectrometry 
(A) MALDI-TOF/TOF spectrum of the 21 kDa protein digested with trypsin. Peaks indicated 
with asterisks were subjected to MS/MS analysis. Peaks indicated with ox, represent methionine 
oxidation products. The peak at 1860, denoted with a P, represents a peptide containing 
polymorphic mutation. (B) Tabular presentation of peaks assigned for group 1 LEA protein 
sequence as determined by DNA sequencing from PCR-based cDNA library screen (for 
corresponding MS/MS spectra, see Figures 2D-2H) (EF6566124). (C) Protein sequence of group 
1 LEA protein where the detected and sequenced peptides from the tryptic digest are underlined, 
while in boxes are identical peptide sequences found to be presented at multiple positions. Amino 
acids in grey colour correspond to the part of the protein from which peptides have not been 
detected or sequenced. Overall sequence coverage from the tryptic digest is 64.8%. 
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Figure 2. continued 
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Figure 2. continued 
MS/MS annotated spectra of tryptic peptides at 1675.0 m/z (F) and 1704.0 m/z (G). 
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Figure 2. continued 
MS/MS annotated spectra of tryptic peptide at 1744.0 m/z (H). 
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sixth peptide ([MH+] 1743.8 m/z) was a lysine miscleavage and oxidized methionine 
version of the previously described unique sequence ([MH+] 1584.0 m/z). Not 
surprisingly, sequences of two peptides identified by MS/MS ([MH+] 1668.8 m/z and 
1704.8 m/z) were present within the group 1 LEA protein in duplicates. The sequence 
coverage from tryptic digest is 64.8%. 
In order to obtain more sequence information pertinent to group 1 LEA protein, 
Glu C generated peptide fragments were analyzed in similar fashion (Figure 3). Overall, 
seven peptides were subjected to MS/MS analysis, five were unique fragments 
representing the group 1 LEA repeats ([MH+] 945.5 m/z, 1100.6 m/z, 1205.7 m/z, 1664.9 
m/z and 2173.1 m/z), while one peptide ([MH+] 1753.9 m/z) was the result of a GluC 
miscleavage ([MH+] 1205.7 m/z). Similar to trypsin generated peptides, one GluC peptide 
([MH+] 1178.6 m/z) was assigned to the group 1 LEA protein three times. The sequence 
coverage from GluC digest is 51.1%. Combined sequence coverage from both proteolytic 
digests is 92.3%. Overall, a novel protein from A. franciscana encysted embryos (p21) 
was identified as a group 1 LEA protein by de novo sequencing. DNA sequence 
corresponding to this protein was corroborated by MS/MS data with high sequence 
coverage. 
Discussion 
As the studies on A. franciscana continue to shed light onto the molecular 
mechanism underlying tolerance to extreme environmental stress conditions, more protein 
families will be identified that facilitate survival of these embryos under virtually 
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Figure 3. Analysis of GluC generated peptides from the 21 kDa protein by matrix-assisted 
laser desorption-ionization (MALDI)-tandem mass spectrometry 
(A) MALDI-TOF/TOF spectrum of the 21 kDa protein digested with GluC. Peaks indicated with 
asterisks were subjected to MS/MS analysis. Peaks indicated with ox, represent methionine 
oxidation products. (B) Tabular presentation of peaks assigned for group 1 LEA protein sequence 
as determined by DNA sequencing from PCR-based cDNA library screen (for corresponding 
MS/MS spectra, see Figures 3D-3J) (EF6566124). (C) Protein sequence of group 1 LEA protein 
where the detected and sequenced peptides from the GluC digest are underlined, while in boxes 
are identical peptide sequences found to be presented at multiple positions. Amino acids in grey 
colour correspond to the part of the protein from which peptides have not been detected or 
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Figure 3. continued 
MS/MS annotated spectra of GluC peptides at 945.0 m/z (D) and 1100.0 m/z (E). 
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Figure 3. continued 
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Figure 3. continued 
MS/MS annotated spectra of GluC peptide at 2173.0 m/z (J). 
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often correlates with improved stress tolerance [7]. A heat-stable cytoplasmic p21 protein 
was identified as a group 1 LEA protein. Following identification, further analysis of this 
protein demonstrated a potential role for group 1 LEA proteins in desiccation tolerance of 
encysted embryos due to its ability to prevent drying-induced protein aggregation [12]. 
LEA family members are predicted to be generally small intrinsically 
unstructured proteins [7, 8]. The A. franciscana group 1 LEA protein is composed of 182 
amino acids, from these 23% are glycine residues, which is in accordance with the group 
1 LEA protein characteristic high content of glycine residues (approximately 18%) [8]. In 
addition, the sequence analysis revealed a large proportion of charged residues, 
contributing to the high hydrophilic nature of this protein. Furthermore, the sequence of 
the A. franciscana homologue lacks cysteines, a general characteristics of group 1 LEA 
proteins. Further supporting evidence that the identified protein is a group 1 LEA member 
is based on the regular spacing of glycine and glutamic acid residues within a period of 
twenty amino acids [7]. Sequence analysis of A. franciscana group 1 LEA protein is in 
agreement with this requirement. 
The A. franciscana group 1 LEA protein contains eight tandem repeats of the 20 
amino acid motif characteristic for group 1 LEA proteins. Overall, the repeats are very 
similar to each other. The first six repeats are 80% identical. The first and second and 
fourth and fifth repeat sequences are 90% identical, while 95% identity is observed 
between second and third and fifth and sixth repeat sequences. The tandem repeats 
become more degenerate towards the carboxy terminus. Repeats six and seven are 75% 
identical, while repeat seven and eight are only 35% identical. Similarly, a group 3 LEA 
protein, AfrLEAl, from A. franciscana displays divergence in nine characteristic repeats 
towards the carboxy terminus [10]. 
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The presence of the tandem motifs described above greatly increased the 
complexity of the MS-spectra annotation. Many ionized peptides corresponded to the 
motif sequences with alterations in one or two amino acids, this caused by the variability 
among the repeats. Additionally, as the original heat stable protein sample was obtained 
from a population of encysted A. franciscana embryos, few polymorphisms were detected 
at the DNA levels as well as by the MS-peptide analysis. Most of the de novo MS/MS 
spectra were annotated manually, however once the PCR-based amplification of this gene 
from embryonic cDNA library was completed, the translated DNA sequence allowed for 
comparison between observed peptides and their corresponding amino acids with in silico 
generated fragments. In silico digest of the group 1 LEA protein was performed with MS-
Digest software from Prospector (available at prospector.ucsf.edu). Other LEA proteins 
have been identified in a proteomic analysis on postdiapaused embryonic development in 
A. franciscana and were annotated based on matches within an in-house generated 
database containing 30,000 ESTs [11]. 
The A. franciscana mRNA for group 1 LEA is detected in diapaused embryos but 
not in swimming larvae [12]. While only encysted embryos are able to withstand 
desiccation for years, this implies a role of group 1 LEA protein in dessication tolerance. 
The identification of a unique 21 kDa protein by MS-based approach, in particular the de 
novo peptide sequence assignment to tandem motif, allowed cloning and characterization 
of the first group 1 LEA protein in animal species. A. franciscana group 1 LEA protein 
might be one of the still many missing pieces from the complex puzzle, which this 
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CHAPTER 3 
Identification of PDI redox sensitive thiols by ICAT-based MS 
This chapter incorporates the outcome of joint research undertaken in collaboration with 
Inga Sliskovic under the supervision of Dr. Bulent Mutus, Department of Chemistry and 
Biochemistry. The collaboration is covered in Chapter 3 of the thesis. In all cases, the 
key ideas, primary contributions, experimental designs, data analysis and interpretation, 
were performed by the authors, and the contribution of co-authors was primarily through 
the provision of recombinant purified protein disulfide isomerase, PDI. Inga prepared the 
PDI protein sample in a reduced and auto-oxidized form. Dr. Eric Simon and Dr. Philip 
Andrews at the Michigan Proteome Consortium, University of Michigan, provided 
knowledge and instrumentation for the peptide separation and MALDI TOF/TOF 
analysis. My contribution to this manuscript was application of the isotope-coded affinity 
tag (ICAT) technology and identification of the cysteine redox state on PDI using mass 
spectrometry (MS). I performed all experimental steps involved in the ICAT labeling 
protocols, followed with acquisition and interpretation of the MS spectra. 
The results were published: Kozarova, A., Sliskovic, I., Mutus, B., Simon, E.S., Andrews, 
P.C., and Vacratsis, P.O. (2007). Identification of redox sensitive thiols of protein 
disulfide isomerase using isotope coded affinity technology and mass spectrometry. J Am 
Soc Mass Spectrom 18, 260-269 
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Introduction 
Protein disulfide isomerase (PDI), a member of the thioredoxin superfamily of 
redox proteins, is an enzyme responsible for disulfide bond formation and isomerization 
[1, 2], redox-dependent chaperone function [3, 4] and S-nitrothiols denitrosation activity 
[5]. Originally, PDI was identified in the lumen of the endoplasmatic reticulum [6, 7] and 
subsequently detected at additional locations, such as the cell surface and the cytosol [8]. 
In the case of secreted PDI, it has been demonstrated to control the redox state of certain 
cell-surface proteins [9]. Furthermore, PDI was identified as a subunit of prolyl 4-
hydroxylase [10, 11] and microsomal triglyceride transfer protein [12, 13], executing 
different functions than in its monomeric state. 
PDI comprises four domains, a, b, b' and a' [14] and an acidic region designated c 
[15-17] (Figure 1A). The two thioredoxin domains of PDI [18], a and a', each contain an 
active site with a consensus sequence WCGHCK, which are separated by two 
thioredoxin-like domains b and b'. The multi-domain structure of PDI is required to 
catalyze thiol-disulfide exchange events and effect folding by inducing conformational 
changes in the substrate protein [19]. Recently, the crystal structure of yeast PDI was 
elucidated and the structure revealed thioredoxin domains arranged in a shape of a twisted 
"U" with the active sites facing each other across the "U" [20]. 
Each PDI molecule contains six cysteine residues. Four of them have been shown 
to be responsible for the redox activity and are present as two vicinal thiol groups within 
each active site. Multiple studies have investigated the relative redox/catalytic 
contributions of the two thioredoxin active sites, and have suggested that they do not have 
equivalent catalytic properties [16, 21]. Furthermore, the NMR structure of human PDI a 
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domain identified the N-terminal cysteine residue, Cys-36, as accessible and exposed 
while the C-terminal cysteine residue, Cys-39, as buried and constrained [22]. In addition, 
the crystal structure of yeast PDI predicted that the two cysteines within the a domain are 
primarily in the oxidized state (modeled as a mixture of oxidized to reduced state at 0.8 to 
0.2 respectively) and the cysteines within the a' domain are in a reduced state [20]. The 
function and regulation of the redox states of the other two cysteine residues present 
within the b' domain of human PDI, remains unclear. 
The redox state of active site cysteines dictates the catalytic activity of PDI. 
Opposite redox states are required to facilitate either oxidation or isomerization reactions, 
i.e. the best oxidases having the least stable disulfides and the best reductases having the 
least stable dithiols [1, 21, 23]. Therefore the thiol/disulfide exchange within the active 
site is required for effective oxidation or disulfide formation on PDI substrates [23]. 
Furthermore, alterations of the redox state balance of PDI underlie different pathological 
conditions. For example, it has been observed, that upon activation/aggregation of resting 
platelets the amount of reduced cell surface PDI increased approximately three fold, thus 
implying that thiol groups are critical for platelet aggregation [24]. 
Common approaches to analyze thiol oxidation states include spectrophotometric 
and fluorescence-based assays [25], however these only provide information regarding 
the average number of modified cysteine residues, not their exact identity. Here, we 
present a method that uses isotope-coded affinity tag based method (ICAT) in conjunction 
with mass spectrometry (MS) [26, 27] to directly detect and quantitate dynamic changes 
in the thiol oxidation state of recombinant human PDI under reducing and auto-oxidizing 
conditions. In addition to the detection of the redox status of the active site cysteines, we 
will offer data indicating redox regulation of Cys-295 present within the b' domain. Also, 
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a novel oxidation modification on an invariable tryptophan residue, Trp-35, adjacent to 
the cysteine residues within the active site, will also be presented. 
Materials and Methods 
Purification of Protein Disulfide Isomerase 
His-PDI was expressed and purified as described previously [5]. Protein quantification 
was performed using the Bradford assay [28] and protein purity was ascertained by SDS-
PAGE. 
PDI reduction and spontaneous auto-oxidation 
Bacterially expressed human His-PDI (100 u.g) was fully reduced with 5x molar excess of 
DTT for 2 hr at room temperature. The DTT was removed during gel filtration on 
Sephadex G-25 in lOOmM phosphate buffer, pH 7. Immediately after separation, the 
reduced PDI was acetone precipitated and labelled with light 12C-ICAT reagent (Applied 
Biosystems). For spontaneous auto-oxidation, PDI was incubated for 1 hr at room 
temperature following the reduction with DTT and gel filtration. Subsequently, this 
sample was also acetone precipitated and labelled with heavy 13C-ICAT reagent (Applied 
Biosystems). 
ICA T labelling of reduced and auto-oxidized PDI 
PDI containing samples were prepared as described above and ICAT labelling and 
purification of labelled peptides was performed following the provided protocol from 
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Applied Biosystems. Briefly, reduced and auto-oxidized PDI was labelled with 12C-ICAT 
and 13C-ICAT reagents, respectively, for 2 hr at 37°C. After alkylation with the 
iodoacetamide-based ICAT reagent, the two samples were mixed together and subjected 
to digestion with Endoproteinase Glu-C for 12 hr at 25°C. Peptides were desalted using a 
cation exchange cartridge and biotin labelled peptides were purified using an avidin 
affinity cartridge provided by Applied Biosystems. Peptides were subsequently dried and 
resuspended in the cleavage reagent in order to release the labelled peptides from the 
biotin moiety by incubation for 2 hr at 37°C. Subsequently, peptides were dried and 
resuspended in 1% formic acid. All samples were desalted using micro-Cis ZipTips 
(Millipore) prior to MALDI MS analysis. 
HPLC separation of ICAT labelled peptides 
ICAT labelled peptides were separated on a LC Packing nanoflow HPLC system (nano-
LC) (LC Packings) with a Zorbax 300 SB Cis column (75(4,m x 150mm, 3.5um particles) 
(Agilent technologies) at a flow rate of 300 nl/min. These peptides were separated using 
multi-step linear gradient of 0 to 30% B in the first 10 min, followed by 30 to 45% B for 
37 min, 45 to 60% B for 5 min and 100% B for 6 min (mobile phase A, 3% acetonitrile, 
0.1% trifluoroacetic acid; mobile phase B, 90% acetonitrile, 0.1% trifluoroacetic acid). 
Column effluent was mixed with MALDI matrix (2mg/ml a-cyano-4-hydroxycinnamic 
acid, lOmM ammonium dihydrogen phosphate in 50:49:1 water/isopropyl alcohol/acetic 
acid) through a mixing tee and spotted automatically with a Probot (LC Packings) onto a 
192-well MALDI target plate. The matrix was delivered to the mixing tee at a flow rate of 
1.2 uL/min. 
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Mass spectrometry analysis 
ICAT labelled peptides were analyzed by MALDI-TOF MS (DE-Pro Voyager, Applied 
Biosystems) and MALDI-TOF/TOF (4700 Proteomics Analyzer, Applied 
Biosystems/MDX Sciex). For the MALDI-TOF MS analysis, the purified labelled peptide 
sample (1:1 matrix solution a-cyano-4-hydroxycinnamic acid) was spotted onto a 
MALDI target plate and analyzed in reflector mode. For the MALDI-TOF/TOF analysis 
MS and MS/MS spectra were acquired in positive ion reflector mode. MS survey scans 
were acquired first for each MALDI well and the ions of interest were selected for 
MS/MS analysis. 
Results and Discussion 
ICAT labelling of PDI 
An ICAT-labelling approach in combination with mass spectrometry was 
developed for the purpose of quantitating changes in the redox state of human His-PDI 
under various conditions, since only free thiols will react with the iodoacetamide-based 
ICAT reagent. Bacterially expressed human PDI was purified to near homogeneity by 
nickel chromatography (Figure IB). To assess if PDI can be labelled with ICAT reagent, 
following reduction with excess reducing agent, the free thiol groups on cysteine residues 
(cysteine-SH) were incubated with acid-cleavable light 12C-ICAT reagent. The ICAT-
labelled protein was digested with Glu-C in order to generate unique peptides 
corresponding to each active site. The [MH+] 2147 m/z ion represents the peptide 
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containing the active site within the a domain, FYAPWC36GHC39KALAPE, containing 
two ICAT labels (molecular mass 227 Da per one ICAT-tag) (Figure 2A). This indicates 
that both cysteines within the a domain were in the reduced state and thus susceptible to 
labelling with the ICAT alkylating agent (confirmed by analysis of MS/MS fragment ion 
series, as described below). Importantly, we did not detect a peak at [MH+] 1924 m/z, 
which would correspond to only one ICAT-labelled cysteine residue. Similarly to the a 
domain active site, a peptide fragment representative of the a' domain active site at 
[MH+] 2916 m/z was modified with two ICAT labels. However, further analysis was 
complicated with the inability of reproducibly detecting this peptide. Thus, this implies 
that under these conditions, cysteine residues within the a' domain peptide 
FYAPWC380GHC383KQLAPIWDKLGE, exist predominantly in their oxidized form and 
are therefore less susceptible to ICAT modifications. 
In addition, peptide fragments corresponding to the two remaining cysteine 
residues of the PDI within the b' domain were also detected (Table 1). Numerous 
peptides were detected encompassing the ICAT-labelled cysteine at position 295, 
specifically EC295PAVRLITLE ([MH+] 1470 m/z) and two peptides corresponding to 
additional mis-cleavages ([MH+] 1729 m/z and [MH+] 2579 m/z). The [MH+] ion 
detected at 1178 m/z corresponded to the other cysteine within the b' domain, Cys-326, 
within the FC326HRFLE peptide. 
Mass spectrometric studies to analyze PDI have been performed in the past. An 
alternative to the ICAT-based labelling method is alkylation of the cysteine residues with 
N-ethylamaleimide (NEM) [29]. In parallel to the ICAT labelling described herein, we 
also modified fully reduced PDI with NEM. Fragments corresponding to active sites 
modified with one or two NEM adducts (125 Da per NEM label) were detected (data not 
69 
WCGHC 39 
C235CS2S WCGHC, 53 
b' 
118 352 462491 
B 





v -̂ I 5* 
< N ^ 
Purify labeled peptides 
'V* -*• HPLC I 
MALDI-MS/MS 
Figure 1. Schematics of ICAT strategy 
(A) A schematic model of domain architecture of human PDI. Domains a, b, b' and a' 
share a common thioredoxin fold, but only the a and a' domain have the WCXXC active 
site. Position of all six cysteine residues within human PDI is highlighted. (B) Bacterially 
expressed, purified human His-PDI was separated using SDS-PAGE (10%) and 
visualized by commassie blue stain. Lane 1 PDI control purchased from Sigma, lane 2 
reduced His-PDI (treated with 5x excess DTT), lane 3 auto-oxidized His-PDI (following 
reduction, PDI was incubated in phosphate buffer for 1 hr at room temperature). (C) 
Schematic presentation of ICAT labelling protocol. PDI was reduced and immediately 
labelled with light 12C-ICAT reagent or incubated at room temperature to allow auto-
oxidation and subsequently labelled with heavy 13C-ICAT reagent and processed as 
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12/ Figure 2. Reduced PDI labelled with light 'X-ICAT reagent 
(A) Full scan MALDI-TOF spectrum of ICAT-labelled Glu-C digested peptides from 
PDI. The [MH+] 2147 m/z fragment corresponds to the a domain active site with both 
Cys residues ICAT labelled. The [MH+] 2916 m/z fragment corresponds to the a' domain 
active site with both Cys residues ICAT labelled. The additional peptide fragments are 
presented in tabulated form, including the theoretical mass prior to Cys modification and 
after modification with corresponding detected ions, i.e. the fragment at [MH+] 1178 m/z 
corresponds to the Cys-326 present in the b' domain while fragments at [MH+] 1470 m/z, 
[MH+] 1728 m/z and [MH+] 2579 m/z represent various mis-cleavages of the sequence 
containing Cys-295. (B) Enlargement from A (range 2135-2195 m/z) showing the ions 
corresponding to addition of+16 Da and +32 Da on the a domain active site peptide. 
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# Start End Cys Sequence Mass (monoisatopic) 12C-ICAT-modified 12C-I CAT-modified 









































6 375 395 380,383 FYAPWCGHCKQLAPIWDKLGE 2462.2 2916.4 2916.2 
Table 1. Recombinant human PDI ICAT-labelled peptides 
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shown). In contrast, the ICAT-modified peptides reproducibly produced only peptides 
labelled on both cysteine residues. Another cysteine alkylating reagent, the episulfonium 
ion derived from S-(2-chloroethyl)glutathione (CEG) has been identified to modify only 
one cysteine residue within each active site of rat PDI, the N-terminal residues Cys-36 
and Cys-380 [30]. In addition, cysteine residues of PDI were indicated to be modified by 
the thiol reactive lipid aldehyde 4-hydroxynonenal (4-HNE) in rat livers fed a 
combination of high-fat and ethanol diet [31], although the modified cysteines were not 
resolved. Overall, these different thiol reactivities may be due to incomplete labelling 
caused by various degrees of hydrophobicity and hydrophilicity of the modifying reagent, 
resulting in limited access to buried and solvent inaccessible regions within PDI. Our 
results indicate that the structural nature of the ICAT reagent is capable of reacting with 
all of the cysteine residues of PDI when they are present in their free thiol form. 
Further analysis of the peptide corresponding to the a domain active site indicated 
two sequential peaks (each 16 Da apart) in addition to the peak analogous to the 
monoisotopic mass of [MH+] 2147 m/z (Figure 2B). These modified light-ICAT labelled 
peptides would likely complicate the analysis when light and heavy ICAT-modified 
samples were to be compared. Specifically, the second generation ICAT reagents, 12C-
(light, addition of 227 Da per one ICAT-tag) and 13C-(heavy, addition of 236 Da per one 
ICAT-tag), have been designed to differ by 9 Da per cysteine residue for quantitation 
purposes [27]. This would result in an addition of 18 Da when two ICAT labelled 
cysteines are present within the active site in the a domain. Therefore due to isotopic 
interference, the discrimination between the +16 Da (light ICAT-label and modified 
peptide ([MH+] 2163 m/z)) and the + 18 Da (heavy ICAT-label and unmodified peptide 
([MH+] 2165 m/z)) would be challenging. 
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In order to resolve this issue, ICAT-labelled peptides were fractionated using 
reverse-phase chromatography (Figure 3). The column elution profile indicated that all of 
the modified peptides were significantly resolved from each other (Figure 3a), and in 
expected order. The peptide corresponding to the active site within the a domain labelled 
with 2 light ICAT-tags and modified by +32 Da eluted first (Figure 3b), followed by the 
peptide modified by +16 Da (Figure 3c), whereas the most hydrophobic, non-modified 
peptide eluted last (Figure 3 c). 
Tryptophan oxidation adjacent to the active site cysteine 
MS/MS analysis identified the peptide at [MH+] 2147 m/z to correspond to the a 
domain active site fragment, FYAPWC36GHC39KALAPE. This peptide contains two 
ICAT labels, one per cysteine residue, as determined from the y6-yio series, the yn 
fragment and the bg,bio-bi4 series (Figure 4A). Further analysis of the fragment ion series 
indicated that the modified residue on the peptide at 2163 m/z and the peptide at 2179 m/z 
was Trp-35. Specifically, the addition of+16 Da ([MH+] 2163 m/z) was identified as 
tryptophan monooxidation (hydroxytryptophan) (Figure 4B) and the addition of +32 Da 
([MH+] 2179 m/z) was due to the tryptophan dioxidized form (JV-formylkynurenine) 
(Figure 4C). 
This is an intriguing modification since Trp-35 is located within the a domain 
active site immediately adjacent to the active site cysteines. Moreover the modified forms 
of the peptide were present in greater yield than the unmodified form (Figure 2). It is 
possible, that this modification was the result of MS sample preparation. However, it has 
been argued that tryptophan oxidation is not a considered mass spectrometry encountered 
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12/ Figure 3. Separation of the modified "C-ICAT-labelled peptides 
(A) Chromatogram showing separation of the Glu-C digested, ICAT labelled peptides on 
a reverse-phase nano-LC column. (B) MALDI-TOF analysis of peptides separated by 
nano-LC. The doubly modified peptide (+32 Da) eluted first ([MH4] 2179 m/z), followed 
by singly modified peptide (+16 Da) ([MH+] 2163 m/z) (C), and the unmodified peptide 
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Figure 4. MALDI-TOF MS/MS analysis of the a domain active site labelled with light l 2C-
ICAT reagent displaying tryptophan oxidation 
(A) MS/MS spectrum of the unmodified peptide ([MH+] 2147 m/z) showing the amino acid 
sequence and position of ICAT modifications. (B) The +16 Da modified peptide ([MH+] 2163 
m/z) was determined to contain a hydroxytryptophan. (C) The +32 Da modified peptide ([MH+] 
2179 m/z) was determined to contain a doubly oxidized tryptophan, N-formylkynurenine. 
Asterisks within the sequence indicates modification of cysteine residues with ICAT reagent,' 
indicates modification of the y- and b-ions by +16 Da (B) and " indicates modification by + 32 
Da (C). (D) Sequence alignment of peptides identified to contain doubly oxidized tryptophan; 
these peptides were identified in the cardiac mitochondrial proteome [33] and from bovine intact 
lens (*)[35]. 
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oxidized tryptophan was identified in a subset of mitochondrial proteins predominantly 
associated with redox metabolism [33] and in the chaperone a-crystallin from bovine lens 
tissue exposed to Fenton chemistry [35]. Sequence analysis of the residue surrounding 
Trp-35 within PDI suggests similarity with these other proteins modified in vivo by 
tryptophan oxidation. In addition, the location of this tryptophan residue immediately 
adjacent to the active site cysteines suggests that tryptophan oxidation may play a role in 
regulating PDI catalysis. 
Dynamic changes in the redox state of PDI active site 
We have previously shown that PDI undergoes auto-oxidation in the absence of 
reducing agents [5]. In order to further characterize and definitively identify the cysteine 
residues altered during auto-oxidation, the ICAT strategy was used to quantify changes in 
the redox state of PDI. Specifically, reduced PDI was labelled with the light 12C-ICAT 
reagent, while auto-oxidized PDI was labelled with the heavy 13C-ICAT reagent (Figure 
1C). These samples were subsequently combined and processed together. Upon 
fractionation of PDI peptides by nano-LC, the relative quantity of thiol oxidation was 
assessed by MS. For the purified a domain peptides, all modified forms displayed 
approximately a 5 to 1 ratio between reduced and auto-oxidized samples (Figure 5). The 
ratio of non-modified tryptophan containing peptides labelled with ICAT-light reagent 
(([MH+] 2147 m/z) can be compared to non-modified tryptophan containing peptides 
labelled with ICAT-heavy reagent ([MH+] 2165 m/z) (Figure 5C). The ratio of the light 
and heavy ICAT labelled hydroxytryptophan containing peptides ([MH+] 2163 m/z and 
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12/ Figure 5. Quantitation of reduced (light C-ICAT-labelled) and auto-oxidized 
(heavy 13C-ICAT-labelled) PDI following reverse-phase nano-LC separation 
(A) Peptides corresponding to the a domain active site containing the doubly oxidized 
Trp, were detected for reduced PDI (light ICAT labelled, [MH+] 2179 m/z) and auto-
oxidized PDI (heavy ICAT labelled, [MH+] 2197 m/z) displaying approximately 5 fold 
decrease in susceptibility to labelling. Peptides corresponding to the a domain active site 
containing the monooxidized Trp ([MH+] 2163 m/z and 2181 m/z) (B) and non-modified 
Trp ([MH+] 2147 m/z and 2165 m/z) (C) were detected for reduced PDI and auto-
oxidized PDI displaying similar auto-oxidation patterns. 
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of N-formylkynurenine containing peptides ([MH ] 2179 m/z and [MH+] 2197 m/z) 
(Figure 5A). 
Redox-induced changes ofb' domain cysteines 
So far, the functional significance of the two cysteine residues within the b' 
domain of the human PDI has not been completely elucidated. Point-mutation studies 
indicate that these residues do not play any role in PDI catalytic activity or substrate 
interaction [19, 36-38]. We observed, that auto-oxidation does not have any effect on 
Cys-326, within the sequence FC326HRFLE ([MH
+] 1178 m/z and [MH+] 1187 m/z), and 
therefore serves as an internal control for the reduced and auto-oxidized samples (Figure 
6). 
Interestingly, auto-oxidation induced changes in the redox state of the other b' 
domain cysteine residue, Cys-295. Two differential cleavage peptides containing Cys-295 
([MH+] 1470 m/z and [MH+] 1479 m/z; [MH+] 1728 m/z and [MH+] 1737 m/z) 
demonstrated a dramatic loss of ICAT reactivity under auto-oxidized conditions (Figure 
6). This result suggests, that in addition to changes within the a domain active site of 
human PDI, Cys-295 within the b' domain is also sensitive to redox regulation. 
The ICAT-based approach used in this study indicated redox regulation of one of 
the two cysteine residues within the b' domain. Specifically, the ability to modify Cys-
295 with ICAT-reagent upon auto-oxidation decreased about five fold. In contrast, Cys-
326 remained susceptible to ICAT-labelling even after auto-oxidation, thus implying that 
this cysteine residue remains in thiol form. This is interesting since a study involving 
chemical modification of an isolated b' domain indicated that neither of these cysteine 



























Figure 6. Redox regulation of Cys-295 within the b' domain 
MALDI-TOF analysis of peptides containing b' domain Cys residues labelled with light 
and heavy ICAT. Similar levels of peptides containing Cys-326 from reduced (light 
ICAT) and auto-oxidized (heavy ICAT) samples were detected at [MH+] 1178 m/z and 
[MH+] 1187 m/z respectively. The Cys-295 containing peptides from two mis-cleavage 
products ([MH+] 1470 m/z and [MH+] 1728 m/z for light ICAT) show a five fold decrease 
in ICAT-labelling upon auto-oxidation ([MH+] 1479 m/z and [MIT"] 1737 m/z). 
80 
redox potential [37]. In contrast, based on the crystal structure of yeast PDI, Cys-90 and 
Cys-97, were elucidated to form a disulfide bond [20]. These two non-active site 
cysteines are part of the a domain of yeast PDI (unlike the b' domain of human PDI) and 
are believed to destabilize the oxidated state of the a domain active site cysteines [39]. 
Our results using full length PDI implicated Cys-295 as an additional redox sensitive site, 
potentially capable of modulating PDI activities. 
This study reports direct detection and conclusive identification of redox induced 
changes on the cysteine residues of recombinant human PDI in the a, b' and a' domains 
using ICAT methodology combined with mass spectrometry. The ICAT data presented 
here agree with the predicted susceptibility to oxidation of the active site vicinal thiols 
within the a domain, in that both of these cysteine residues were reactive towards ICAT-
reagent in the fully reduced enzyme. However, the ICAT-signal of these thiols decreased 
by five fold upon auto-oxidation. In contrast, the a' active site cysteine residues could not 
be reliably labelled with ICAT-reagent, and are thus probably present in an oxidized state. 
This is in accordance with the decrease of total cysteine content upon auto-oxidation as 
determined by reactivity with 5,5'-dithiobis(nitrobenzoic acid) [5]. In conclusion, PDI 
activity is redox dependent and regulated; therefore we developed a method to study 
direct dynamic changes in the redox state of PDI. 
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CHAPTER 4 
Identification of hYVHl phosphorylation sites by MS and their function 
This chapter incorporates the outcome of joint research undertaken in collaboration with 
Dr. John W. Hudson, Department of Biological Sciences. The collaboration is covered in 
Chapter 4 of the thesis. In all cases, the key ideas, primary contributions, experimental 
designs, data analysis and interpretation, were performed by the authors, and the 
contribution of co-authors was through the provision of experimental help, analysis and 
data interpretation with flow cytometry based approach. My contribution to this 
manuscript in preparation was identification of phosphorylation sites on Flag-hYVHl 
expressed and immunoprecipitated from mammalian cells; generation of phosphomutants, 
localization experiments, RNAi experiments and characterization of the phenotype, as 
well as sample processing for flow cytometry experiments. 
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Introduction 
Protein phosphorylation (by protein kinases) and dephosphorylation (by protein 
phosphatases) is a universal regulatory mechanism controlling a vast array of signalling 
pathways and physiological processes [1-4]. Dual specificity phosphatases (DUSPs) 
encompass a group of heterogeneous and versatile enzymes that are able to remove 
phosphate moieties from phosphotyrosine and phosphoserine/threonine residues [5]. The 
best characterized role of DUSPs is the regulation of proline directed kinase families such 
as the mitogen activated protein kinases (MAPKs) and the cyclin dependent kinases 
(CDKs). 
Atypical dual specificity phosphatases represent a DUSP subfamily and consist of 
generally smaller enzymes (only three members of this subgroup are bigger than 27 kDa), 
and lack the N-terminal Cdc25 homology 2 domain (which is typical for DUSPs) [5]. 
Therefore, it is postulated that most atypical DUSPs are not direct regulators of MAPKs 
or CDKs. Furthermore, certain atypical DUSPs contain unique domain architectures that 
likely dictate distinctive cellular functions; e.g. laforin contains a carbohydrate binding 
domain [6], DUSP 11 has arginine- and proline-rich regions [7] and DUSP 12 
encompasses a zinc binding domain [8, 9]. 
Human YVHl, (hYVHl, DUSP 12) contains a conserved N-terminal catalytic 
domain and a novel C-terminal zinc-binding domain [9]. Thus it is not surprising, that 
upon clustering analysis of human atypical dual specificity phosphatases, hYVHl appears 
on a separate branch of the dendogram [10]. Disruption of yeast DUSP 12 (YVHl) causes 
a slow growth phenotype [11], which can be complemented by the human orthologue 
(hYVHl), or a mutant containing a catalytically inactivating version of hYVHl (hYVHl -
C115S). This ability to rescue the mutant phenotype is lost upon deletion of the C-
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terminal zinc binding domain [9]. Additional phenotypes due to deletion of YVHl in 
yeast include defects in glycogen metabolism and spore maturation [12]. A yeast two-
hybrid screen identified YPH1 (yeast pescadillo homo log, Nop7) as a yeast YVHl 
interacting partner [13]. Nop7 is required for multiple activities during 60S ribosomal 
synthesis [14]. Interestingly, YVHl was also recently identified as a 60S trans-acting 
factor in a mass spectrometry (MS)-based analysis of pre-60S particles [15]. It was 
further shown that interplay between YVHl and Mrt4 is required for the late maturation 
step of the 60S subunit [16, 17], thus highlighting the role of YVHl in the ribosomal 
biogenesis pathway. 
Human YVHl was found by a MS-based approach to interact with Hsp70 [18]. 
Over-expression of hYVHl repressed cell death induced by cellular insults, such as heat 
shock, hydrogen peroxide exposure and Fas receptor activation. This repression is further 
enhanced upon co-expression with Hsp70 [18]. Also, a role for hYVHl in tumourigenesis 
is supported by a recent clinical study, in which hYVHl was shown to be selectively and 
highly overexpressed in CD34+ progenitor cells from chronic myelogenous leukemia 
patients [19]. However, hYVHl remains a poorly understood phosphatase especially 
regarding how its activities are regulated in the cell. 
Here we report the first identified phosphorylation sites within hYVHl using a 
MS based approach. The sites were further characterized in terms of their effect on 
hYVHl localization and DNA content of cells over-expressing the phosphomimetic and 
non-phosphorylatable mutants. In addition, the cell cycle phenotype observed due to 
down-regulation of hYVHl is also described. 
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Materials and methods 
DNA plasmids 
Flag-hYVHl and C115S were described previously [9]. Domain specific 
constructs, i.e. Flag-hYVHl,.192 (ACTl), Flag-hYVHl,.26g (ACT2), Flag-hYVHli.282 
(ACT3), and Flag-hYVHl ,93.340 (Zn-binding domain) were described previously [18]. 
The mutants S335A and S335E, were generated by replacement of hYVHl amino 
acids sequence 331-340 flanked by Sspl and BamHI sites with synthetic oligonucleotide 
duplexes containing the mutation, sequences as follow; for S335A oligol 5'ATTGCCTG 
TTTTGGGAGCACAAACAGGAAAGATCTGAG 3', oligo2 5'GATCCTTCAGATCTT 
TCCTGTTTGTGCTCCCAAAACAGGCAAT 3'; for S335E oligol 5'ATTGCCTGTTT 
TGGGAGAACAAACAGGAAAGATCTGAG 3' and oligo2 5'GATCCTCAGATCTTT 
CCTGTTTGTTCTCCCAAAACAGGCAAT 3'. 
The S14A and S14E mutations were introduced using the QuikChange site-
directed mutagenesis kit (Stratagene). Primers are as follows, for S14A primer 1 
5'GATGGCTGCGAGCTCGCCAACCCCAGCG 3', primer2 5'CGCTGGGGTTGGCG 
AGCTCGCAGCCATC 3'; and for SHE primerl 5'GATGGCTGCGAGCTCGAGAAC 
CCCAGCGCCAG 3' andprimer2 5'CTGGCGCTGGGGTTCTCGAGCTCGCAGCCAT 
C 3'. Multiple mutations were introduced in stepwise manner using the site-directed 
mutagenesis approach. 
Flag-hYVHl phosphomimetic TP mutants were generated by QuickChange site-
directed mutagenesis kit (Stratagene) following the manufacturer protocol. Primers are as 
follows, for T252A primerl 5'GCCCACAAGAGAATGGCACCATCTTCCATG 3', 
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primer2 5'CATGGAAGATGGTGCCATTCTCTTGTGGGC 3'; and for T252E primerl 
5 'CCCACAAGAGAATGGAACCATCTTCCATGCTTACCAC 3', primer2 5' GTGGT 
AAGCATGGAAGATGGTTCCATTCTCTTGTGGG 3'. 
All mutations were verified by DNA sequencing. 
Tissue culture, transfections and treatments 
HEK 293 (ATCC) cells were maintained in Dulbecco's modified eagle's medium 
nutrient mixture F-12 HAM (Sigma) supplemented with 10% fetal bovine serum (FBS, 
Sigma) and 2mM glutamine (Gibco); HeLa cells (ATCC) were grown in DMEM 
(Thermo Scientific) containing 10% FBS at 37°C and 5% C02. Transient transfections 
were performed either by Fugene HD (Roche) following manufacturer directions or by 
calcium phosphate method [20] for 24-48 hr. For treatment with phosphatase inhibitors, 
cells were exposed to calyculin A (Cal A; lOOnM; LC Laboratories) for 30 minutes, 
okadaic acid (OA; 5uM; LC Laboratories) for 30 minutes, cyclosporin A (CsA; lOuM; 
LC Laboratories) for 24 hr or dimethylsulphoxide (solvent), prior to lysis. 
For MAPK inhibitors, cells were treated with SB 203580 (lOuM, LC 
Laboratories), SP600125 (40uM, LC Laboratories), U0126 (lOuM, LC Laboratories) for 
1 hr prior to lysis. For combination experiments, first cells were treated with MAPK 
inhibitors for 30 min prior to addition of Cal A, and then both inhibitors were incubated 
together for an extra 30 min. 
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Immunoprecipitation experiments 
Transfected cells were lysed in 50mM Tris 7.5, 150mM NaCl, 1% Triton X-100, 
0.1% SDS containing 100 ug.ml"' aprotinin, ImM phenylmethylsulphonyl fluoride and 
50mM sodium fluoride, and then centrifuged at 20,000g for 30 minutes at 4°C. The 
cleared cell lysates were incubated with pre-equilibrated anti-Flag M2 agarose (Sigma) 
for 3 hr, followed by three washes in wash buffer (50mM Tris 7.5, 150mM NaCl, 0.1% 
Triton X-100, 0.1% SDS). For dephosphorylation experiments, immunoprecipitated Flag-
hYVHl was treated with 30U calf intestinal alkaline phosphatase (CIP, Promega) for 30 
minutes at 37°C. Proteins were resolved on 10% SDS-PAGE gels and stained first with 
Pro-Q Diamond phosphoprotein stain (Molecular Probes) using manufacturer provided 
protocol and visualized on Molecular Imager FX (Bio-Rad). Thereafter, gels were either 
silver stained [21] or coomassie brilliant blue G stained. 
Preparation of phosphopeptides and MS analysis 
Peptides were prepared by in-gel digestion of immunoprecipitated Flag-hYVHl 
separated on SDS-PAGE gel [22]. Briefly, bands corresponding to Flag-hYVHl were 
excised and incubated in destain solution (50% acetonitrile, ACN, HPLC-grade Burdick 
& Jackson, and 50% 50mM ammonium bicarbonate, Fisher) for 35 minutes at 37°C. 
Afterwards, gel pieces were dehydrated in 100% ACN and dried for 20 minutes in a 
speed vac. Protein were digested with either Endoproteinase GluC (Roche) or sequencing 
grade modified trypsin (Promega) following manufacturer directions. Peptides were 
collected by extraction with 60% ACN and 1% formic acid. Collected peptides were 
desalted on C,g ZipTip (Millipore) or Cis spin columns (Vivascience) following 
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manufacturers supplied protocol prior to MALDI-TOF analysis (Applied Biosystems 
Voyager, DE PRO instrument). 
In order to enrich for low abundance phosphopeptides, desalted peptides were 
subjected to PHOS-select™ Iron Affinity Gel (Sigma), using the manufacturer provided 
protocol. Briefly, peptides were incubated with pre-equilibrated bead slurry (in 250mM 
acetic acid, 30% ACN). Non phosphorylated peptides were removed (250mM acetic acid, 
30% ACN) and phosphopeptides were eluted (400mM ammonium hydroxide). Samples 
were desalted as describe above. Peptides were mixed with matrix (10 mg/ml a-cyano-4-
hydroxycinnamic acid in 60% ACN and 1% formic acid), and spotted onto MALDI-plate. 
MS instrument was calibrated with Sequazyme peptide mass standards kit (Applied 
Biosystems). The peptide finger-print was acquired in positive linear mode, with the 
accelerating voltage set to 25,000V, grid voltage set to 94%, guide wire to 0.05% and the 
extraction delay time to 100 nsec. Spectra were analyzed using the Data Explorer 
Software (Applied Biosystems). Experimental peptide masses were compared to 
theoretical values calculated by ProteinProspector MS-Digest Program (available at 
http://prospector.ucsf.edu). 
siRNA experiments 
Endogenous hYVHl was down-regulated by transfection with Lipofectamine 
RNAiMAX (Invitrogen) of Stealth siRNA duplex oligonucleotides (CCUGGAAACUAU 
GCUUUACAUGGCA; Invitrogen) for 48 hr, following manufacturer provided protocol. 
As a negative control, cells were transfected with Stealth RNAi Negative universal 
control low GC duplex #3 (Invitrogen). Prior to immunoblot analysis, Bradford assay 
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(BioRad) was performed to determine the total amount of proteins in pre-cleared lysates. 
Proteins resolved on SDS-PAGE were transferred electrophoretically to PVDF 
membrane, which were probed with optimal dilutions of primary antibodies (endogenous 
anti-hYVHl [9], anti-actin (Sigma)), followed by secondary antibody (anti-rabbit HRP, 
BioRad). Antibody conjugates were detected by SuperSignal west femto maximum 
sensitivity substrate (Thermo Scientific) according to manufacturer's directions. 
Immunofluorescence analysis 
HeLa cells grown on glass cover-slips were fixed in phosphate-buffered saline 
(PBS) containing 3.7% paraformaldehyde and 0.1% Triton X-100 for 12 minutes at room 
temperature. After washing with PBS, cells were permeabilized in PBS containing 0.1% 
Triton X-100 for 2 minutes at room temperature. Prior to incubation with antibodies, cells 
were blocked by 10% BSA for 30 minutes at 37°C. Cells were the incubated with anti-
Flag M2 monoclonal antibody (Sigma) at 1:500 in Tris-buffered saline containing 0.1% 
Tween-20 (TBST) for 1 hr at room temperature, followed by washes in TBST. Primary 
antibody was visualized by incubation with fluorescein-conjugated anti-mouse (Vector 
Labaratories) at 1:500 for 30 minute at room temperature. DNA was counterstained with 
Hoechst 33342 (Molecular Probes) prior to mounting with SlowFade Antifade (Molecular 
Probes). Images were acquired on Zeiss Axioskop 2 (motplus) microscope equipped with 
Qlmagin Qcam camera and analyzed with Northern Eclipse software. 
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Flow cytometry analysis 
Adherent HEK 293/HeLa cells expressing Flag-hYVHl and various mutants were 
trypsinized (Sigma) and cells were harvested by centrifugation at 50g for 5 minutes. 
Pelleted cells were first resuspended in a PBS wash, harvested by centrifugation, then 
fixed overnight in ice cold 80% ethanol. Cells were then pelleted by centrifugation at 
300g for 5 minutes, washed in PBS and then 1% BSA in PBS. Cells were permeabilized 
in 0.25% Triton X-100 in PBS for 5 minutes at room temperature, then PBS was added 
prior to next centrifugation step. Transfected cells (for over-expression experiments) were 
identified by staining with anti-Flag M2 monoclonal antibody (1:100) for 1 hr at room 
temperature, followed by 1% BSA in PBS wash and detected by a horse anti-mouse 
fluorescein antibody (1:30). siRNA transfected cells (down-regulation experiments) were 
identified by a lack of staining with endogenous anti-hYVHl antibody. Cells were stained 
as described above, except non-transfected cells were detected by staining with anti-
hYVHl (1:100) and goat anti-rabbit fluorescein (Vector Labaratories) antibodies. After 
antibody labelling, cells were washed in 1% BSA in PBS and incubated with RNase A for 
30 min prior to addition of propidium iodide (Sigma) for detection of DNA content. As 
negative and internal controls, unlabelled sample, singly labelled samples and sample 
labelled only with secondary antibody were included. Two-colour analysis was performed 
on Cytomics FC500 (Beckman Coulter) using CXP analysis software. 
Senescence /3-galactosidase assay 
Detection of senescent cells was performed according to the protocol provided with a 
senescence P-galactosidase staining kit (Cell Signaling) with minor modifications. 
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Briefly, siRNA transfected HeLa cells were washed in PBS and fixed in 2% 
formaldehyde for 15 minutes at room temperature. After washing, cells were incubated 
overnight at 37°C in freshly prepared solution of 5-bromo-4-chloro-3-indolyl-P-D-
galactopyranoside in 40mM citric acid/sodium phosphate 6.0, 150mM NaCl, 2mM 
MgCl2, and 5mM potassium ferricyanide. Cells were visualized on a Zeiss Axiovert 40 CFL 
microscope in bright field and images were acquired with MicroPublisher 3.3 RTV camera and Q 
Capture acquisition software. 
Results 
hYVHl is regulated by phosphorylation 
In order to elucidate whether hYVHl is regulated by phosphorylation, the total 
levels of phosphorylation on Flag-YVHl immunoprecipitated from transiently transfected 
cells were analyzed by the fluorescent Pro-Q Diamond phosphostain. This fluorescent dye 
detects phosphorylation on serine, threonine and tyrosine residues, and thus after total 
protein staining with Coomassie brilliant blue, relative changes in phosphorylation levels 
can be quantitated by densitometry. Upon treatment of Flag-hYVHl expressing cells with 
the PP1 and PP2A inhibitor calyculin A, total phosphorylation was increased about five 
fold. Furthermore, when Flag-hYVHl was immunoprecipitated from cells previously 
treated with calyculin A and then incubated with alkaline phosphatase there was a 
decrease in the total phosphorylation along with diminished levels of higher molecular 
weight species (Figure 1A). The identification of the higher molecular weight band as 
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Figure 1. Phosphorylation of hYVHl 
(A) Flag-tagged hYVHl was immunoprecipitated from HEK 293 cells and total 
phosphorylation status was analyzed by staining with Pro-Q Diamond phosphoprotein 
stain followed by silver staining. 30 minutes prior to lysis, cells were treated with either 
phosphatase inhibitor calyculin A (Cal A; lOOnM) or DMSO (negative control), and 
afterwards, immunoprecipitated proteins were dephosphorylated by treatment with calf 
intestinal phosphatase (CIP). (B) Transfected cells were treated for 30 minutes prior to 
lysis with phosphatase inhibitors Cal A, okadaic acid (OA; 5uM) or 24 hr with 
cyclosporin A (CsA; lOuM). Total phosphorylation status was visualized with Pro-Q 
diamond stain, followed by Coomassie brilliant blue staining. (C, D) MS-spectra 
corresponding to Flag-hYVHl peptide fingerprint generated with endoproteinase GluC 
(C) and trypsin (D). Peptides were obtained from in-gel digestion of immunoprecipitated 
Flag-hYVHl treated with Cal A prior to lysis. The upper panel is a representative of a 
sample prior to phosphopeptide enrichment; the lower panel displays a spectra following 
the phosphopeptide enrichment step. Arrows indicate phosphopeptides. Peptide identities 
were confirmed by post-source decay analysis (MS-MS). 
96 
calyculin A, treatment with another PP2A phosphatases inhibitor, okadaic acid, caused a 
similar effect thus confirming our previous result. Consistent with these observations, 
cyclosporin A, a PP2B inhibitor, did not affect the total phosphorylation status of Flag-
hYVHl (Figure IB). 
In order to identify the sites of phosphorylation, a MS-based approach was 
employed. Peptides were generated by in-gel digestion with endoproteinase Glu C (Figure 
1C) and trypsin (Figure ID) and analyzed by matrix assisted laser desorption/ionization 
time of flight (MALDI-TOF) MS. As ionization of phosphopeptides are commonly 
suppressed by non-phosphopeptides (upper panels), immobilized metal affinity 
chromatography (IMAC) [23] was carried out to enrich for phosphorylated hYVHl 
peptides. IMAC purification followed by MALDI-post source decay analysis allowed us 
to identify three hYVHl phosphorylation sites; one within the extreme N-terminal region, 
corresponding to residue Serl4, one in the extreme C-terminal region, at amino acid 
position Ser335 and one within the Zn-binding domain, corresponding to Thr252 (Figure 
1C-D, lower panels). These results are the first reported phosphorylation sites for any 
YVHl orthologue and provide an opportunity to learn a fundamental aspect of hYVHl 
function and regulation. 
Ser 14 phosphorylation affects hYVHl localization and cell cycle progression 
Human YVHl has been shown to display a nuclear, perinuclear and cytoplasmic 
localization pattern in a variety of cell lines [9, 16, 18] indicating hYVHl exhibits 
nuclear/cytoplasmic shuttling. In order to elucidate a potential role of Serl4 
phosphorylation on hYVHl localization, we examined the localization patterns of non-
phosphorylatable S14A and phosphomimetic S14E mutants in HeLa cells (Figure 2). 
Consistent with previous reports, wild type FLAG-hYVHl displayed a nuclear, 
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Figure 2. Analysis of hYVHl N-terminal phosphorylation site 
(A) Subcellular localization was analyzed in HeLa cells for Flag-tagged hYVHl and non-
phosphorylatable and phosphomimetic mutants, SKA and S14E, respectively. 
Transfected cells were detected by anti-Flag antibody staining, and were counterstained 
with Hoechst 33342. Scale bars represent 15 microns. (B) Cell cycle profile of transfected 
cells presented as representative histogram data plots. HEK 293 cells were transfected 
with expression vectors encoding either empty vector or Flag-hYVHl (as indicated), 
harvested after 48hr, stained for transfected cells, counterstained with propidium iodide 
and then subjected to a double colour flow cytometry analysis. (C) HEK 293 cells were 
transfected with expression vectors encoding either empty vector, Flag-hYVHl or Flag-
hYVHl C115S (as indicated), harvested after 48hr, stained for transfected cells, 
counterstained with propidium iodide and then subjected to a double colour flow 
cytometry analysis. The graph shows the percentage change in cell cycle phase relative to 
empty vector control; data shown is a representative of at least three independent 
experiments. (D) Cell cycle profile of cells expressing Serl4 non-phosphorylatable and 
mimetic mutants presented as representative histogram data plots. Cells were processed as 
described in B. (E) The graph displays a percentage change in cell cycle phase of N-
terminal mutants relative to empty vector control; data shown is a representative of at 
least three independent experiments. 
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perinuclear and cytoplasmic localization pattern (Figure 2A). It is noted that hYVHl was 
not detectable within the nucleolus and that in most instances the shape of the nuclei in 
transfected cells had a distinct morphology in comparison to neighbouring non-
transfected cells (Figure 2A). The SKA mutant displayed a mainly nuclear localization 
pattern similar to that found with wild-type Flag-hYVHl but more predominant. As with 
wild-type over-expression, there were regions lacking staining within the nucleus that 
were presumed to be nucleoli. The S14E mutation, on the other hand, was predominately 
localized in the cytoplasm, although some nuclear staining was also detected (Figure 2A). 
Unexpectedly, we also noted an overall increase in the number of mitotic-like 
cells in all hYVHl variants in comparison to the controls transfected with the Flag-empty 
vector. In order to further characterize this phenotype, we examined hYVHl over-
expression on cell cycle profiles by flow cytometry utilizing a double colour analysis, in 
which we gated on cells positive for the presence of individual Flag-hYVHl constructs. 
Interestingly, there was a substantial decrease in the percentage of cells in Go/Gi, an 
unchanged percentage of cells in S, and a large increase in the proportion in G2/M and 
polyploid cells as compared to controls (cells either untransfected or transfected with 
Flag-empty vector) (Figure 2B). The enzymatically inactive mutant, Flag-hYVHl C115S, 
displayed a similar cell cycle profile to Flag-hYVHl (Figure 2C), thus suggesting that 
phosphatase activity is not required for hYVHl's effect on the progression through the 
cell cycle. When the DNA content of cells transfected with the S14A mutant was 
analyzed, a similar pattern to that for Flag-hYVHl was observed. However, the mutant 
mimicking phosphorylation at Serl4 (S14E) caused a more substantial decrease in the 
proportion of cells in G0/G1, and an increase in polyploid cells when evaluated against 
Flag-hYVHl (Figure 2D-E). Together, these observations indicate that hYVHl over-
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expression causes an overall increase in 2N DNA content. Furthermore, an N-terminal 
mutant mimicking the phosphorylated residue, S14E displays a marked increase in cells 
containing more that 2N DNA content. 
Ser335 phosphorylation affects cellular DNA content 
In order to assess the functionality of the C-terminal phosphorylation site, non-
phosphorylated S335A and phosphomimetic S335E mutations were introduced into Flag-
hYVHl and their effects on hYVHl localization and cell cycle progression were 
analyzed. Similar to the S14A mutant, the S335A mutant mainly displayed a nuclear 
localization pattern with some cytoplasmic staining, while the S335E mutant (like S14E) 
was predominately present in the cytoplasm (Figure 3A). In addition, over-expression of 
the phosphomimetic S335E mutant resulted in cells displaying multiple nuclei. This was 
further confirmed using flow cytometry. Cells overexpressing FlagYVHl-S335E 
displayed an increase in 2N DNA content i.e. an increase in percentage of cells in G2/M 
phase, when compared to Flag-hYVHl expressing cells (Figure 3B-C). 
The other phosphorylation site identified within the Zn-binding domain was 
Thr252. As a proline is immediately following this phosphorylation site, we asked 
whether proline directed phosphorylation at T252 could be regulated by MAPKs. As a 
preliminary approach, we tested if various MAPK inhibitors were capable of reducing the 
levels of phosphorylated hYVHl in vivo. Flag-hYVHl expressing cells were treated with 
MAPK inhibitors, SB 203580 (inhibits p38), SP600125 (an inhibitor of JNK) and U0126 
(inhibits ERK through inhibition of its upstream activator MEK) alone or in combination 
with calyculin A. Changes in the phosphorylation status of immunoprecipitated proteins 
were analyzed by Pro-Q diamond dye. Based on three independent experiments, the total 
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anti-Flag Hoechst 33342 composite 
Figure 3. Analysis of hYVHl C-terminal phosphorylation site 
(A) Subcellular localization was analyzed in HeLa cells for Flag-tagged hYVHl and non-
phosphorylable and phosphomimetic mutants, S335A and S335E, respectively. 
Transfected cells were detected by anti-Flag antibody staining, and were counterstained 
with Hoechst 33342. Scale bars represent 15 microns. (B) Cell cycle profile of transfected 
cells presented as representative histogram data plots. HEK 293 cells were transfected 
with expression vectors encoding either Flag-hYVHl S335A or Flag-hYVHl S335E (as 
indicated), harvested after 48hr, stained for transfected cells, counterstained with 
propidium iodide and then subjected to a double colour flow cytometry analysis. (C) The 
graph shows the percentage change in cell cycle phase in cells transfected with C-
terminal mutants relative to empty vector control; data shown is a representative of at 
least three independent experiments. 
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phosphorylation status was decreased upon combination treatment with SP600125 and 
calyculin A (Figure 4A). This result suggests that JNK could be one of the upstream 
regulators of Flag-hYVHl but requires further investigation. However, this 
phosphorylation event has no detectable affect on hYVHl function in terms of 
localization and ploidy of cells. When the non-phosphorylated T252A and phospho-
mimetic T252E mutations were introduced and their ability to affect distribution in the 
cell by localization were analyzed, in both cases mainly a nuclear pattern was observed 
(Figure 4B). Regions within the nucleus that lacked staining were tentatively identified as 
nucleoli. Additionally, the cell cycle profiles of cells expressing these mutants were 
indistinguishable from cells transfected with Flag-hYVHl (Figure 4C). 
The phosphomimetic mutants, S14E and S335E display localization phenotypes 
opposite to those observed for the non-phosphorylatable mutants, S14A and S335A. We 
were next interested in determining whether phosphorylation of these sites acts in a 
concerted fashion with regards to localization and cell cycle profiles. We therefore 
examined the effect of double mutant constructs containing both sites mutated at the same 
time (double AA and double EE mutants) as well as mutants of all three identified sites 
(triple AAA and triple EEE mutants) on localization (Figure 5A). Not surprisingly, we 
found a similar distribution to that previously found for the corresponding single mutants 
with the SKA and S335A mutations mainly nuclear with some cytoplasmic staining and 
SKE and S335E mutations mainly cytoplasmic. 
In contrast, the cell cycle analysis of cells transfected with Flag-hYVHl SKA 
S335A (AA) as well as Flag-hYVHl SKA T252A S335A (AAA) showed less of an 
effect on the proportion of cells in Go/Gi compared to Flag-hYVHl, and on the 
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Figure 4. Analysis of hYVHl TP phosphorylation site 
(A) HEK 293 cells were transfected with Flag-hYVHl and treated for lhr prior to lysis 
with MAPK inhibitors SB 203580 (lOuM), SP600125 (40uM), U0126 (lOuM) without or 
with calyculin A (Cal A). Total phosphorylation status was visualized with Pro-Q 
diamond stain, followed by coomassie brilliant blue staining. Densitometry values are 
presented as ratios of ProQ/coomassie band intensities; DMSO treated Flag-hYVHl was 
assigned an arbitrary value of 1.0. Densitometry values were acquired with ImageJ 
software and are representative of at least three independent experiments. (B) Subcellular 
localization was analyzed in HeLa cells for Flag-tagged hYVHl and non-phosphorylable 
and phosphomimetic mutants, T252A and T252E, respectively. Transfected cells were 
detected by anti-Flag antibody staining, and were counterstained with Hoechst 33342. 
Scale bars represent 15 microns. (C) HEK 293 cells were transfected with expression 
vectors encoding either Flag-hYVHl T252A or Flag-hYVHl T252E (as indicated), 
harvested after 48hr, stained for transfected cells, counterstained with propidium iodide 
and then subjected to a double colour flow cytometry analysis. The graph shows the 
percentage change in cell cycle phase of transfected cells relative to empty vector control; 
data shown is a representative of at least three independent experiments. 
105 
A 
anti-Fla." Hoechst 33342 composite 
8 
Flag-hYVHl 



















- : 5 -
'.*HE?'V 'crEr;-
S14AS35A £14AT2:AS335A S14ES335E S14ETS:ES335E 
PA1 pXTj 7EFJ 7EEET 
,- G, G: 
» G . M 
• jxitypJoid 
I ., « B I ,, ^ a . i T . S . I ._ a S.I 
106 
Figure 5. Analysis of hYVHl double and triple phosphorylation site mutants 
(A) Subcellular localization was analyzed in HeLa cells for Flag-tagged hYVHl and 
double and triple non-phosphorylable and phosphomimetic mutants, Flag-hYVHl SKA 
S335A (AA), Flag-hYVHl SKA T252A S335A (AAA) and Flag-hYVHl S14E S335E 
(EE) and Flag-hYVHl SHE T252E S335E (EEE), respectively. Transfected cells were 
detected by anti-Flag antibody staining, and were counterstained with Hoechst 33342. 
Scale bars represent 15 microns. (B) HEK 293 cells were transfected with expression 
vectors encoding either Flag-hYVHl SKA S335A (AA), Flag-hYVHl SKA T252A 
S335A (AAA) and Flag-hYVHl SHE S335E (EE) or Flag-hYVHl SHE T252E S335E 
(EEE) (as indicated), harvested after 48hr, stained for transfected cells, counterstained 
with propidium iodide and then subjected to a double colour flow cytometry analysis. The 
graph shows the percentage change in cell cycle phase of transfected cells relative to 
empty vector control; data shown is a representative of at least three independent 
experiments. 
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comparable to cell cycle profiles of Flag-empty vector than cells expressing Flag-hYVHl. 
Thus the triple A mutation abrogates the phenotype caused by over-expression of Flag-
hYVHl (Figure 5B). Meanwhile, the Flag-hYVHl SHE T252E S335E mutant (EEE) 
displays a similar effect on the progression through cell cycle as Flag-hYVHl (Figure 
5A). 
The zinc binding domain mediates the hYVHl induced cell cycle profile 
In yeast, the C-terminal Zn-binding domain is able to complement the slow-
growth phenotype of a yvhl deletion [12, 24], rescue the 60S export defect [16, 17, 24], 
and is necessary for glycogen accumulation, growth and spore maturation [12]. In 
humans, this domain has a protective function offering intrinsic redox buffering capacity 
and is necessary for the cytoprotective function of hYVHl [18, 25]. We therefore tested 
the over-expression of the Zn-binding domain as well as three different C-terminal 
deletion constructs for their effect on cell cycle progression. The ACTl construct 
terminates right after the phosphatase catalytic domain, the ACT2 variant in addition to 
the catalytic domain contains the first zinc coordination site, and the ACT3 variant 
contains an additional hydrophobic motif, which is highly conserved among orthologues 
[18]. 
The N-terminal catalytic domain (ACTl) essentially had a similar profile as our 
Flag-empty vector control, indicating the importance of the zinc binding domain for the 
hYVHl cell cycle phenotype. Interestingly, over-expression of both partial (ACT2 and 
ACT3) and the complete C-terminal Zn-binding domain resulted in a large decrease in the 
population of Go/Gi cells and a large increase in the population of G2/M and polyploid 
cells (Figure 6A-B). The strongest effect was found with the entire Zn-binding domain. 
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These results strongly suggest that the Zn-binding domain is necessary and sufficient for 
hYVHl mediated cell cycle changes. 
Knockdown of hYVHl expression blocks cells in Go/Gj and induces cellular senescence 
The above experiments demonstrate that over-expression of hYVHl reduces 
Go/Gi and increases the percentage of cells in G2/M and the percentage of cells displaying 
DNA content greater than 2N. To complement these results, we analyzed the cell cycle 
profile of cells that had hYVHl expression knocked down by double stranded small 
interfering RNA (siRNA). The hYVHl siRNA oligonucleotide was transfected into both 
HeLa and HEK293 cells and resulted in approximately an 80% decrease in hYVHl 
expression, while actin levels remained unchanged (Figure 7E). The loss of hYVHl 
expression was accompanied by a striking increase in the G0/G1 population of cells and 
subsequent decrease in other cell cycle phases (Figure 7A-B). When we gated on cells 
that were not expressing hYVHl, approximately 90% of the cells were in G0/G1 (Figure 
7A). 
Since cells that arrest in G0/G1 for prolonged periods are susceptible to permanent 
cell cycle arrest, we were interested in investigating if hYVHl can influence cellular 
senescence. Therefore, cells treated with hYVHl siRNA were stained for the senescent 
marker p-galactosidase and analyzed at different time periods (Figure 7C). Staining of 
hYVHl siRNA treated cells revealed that post seven days siRNA there was a 
reproducible increase in the proportion of senescent cells (Figure 7C-D). Coupled to the 
over-expression data, these results demonstrate for the first time, that hYVHl is a novel 
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Figure 6. Effect of domain specific constructs on progression through cell cycle 
(A) Cell cycle profile of transfected cells presented as representative histogram data plots. 
HEK 293 cells were transfected with expression vectors encoding either Flag-hYVHl 1.192 
(ACTl), Flag-hYVHl 1.268 (ACT2), Flag-hYVHl,.282 (ACT3), or Flag-hYVHl,93-340 (Zn-
binding domain) (as indicated), harvested after 48hr, stained for transfected cells, 
counterstained with propidium iodide and then subjected to a double colour flow analysis. 
(B) The graph shows the percentage change in cell cycle phase in cells transfected with 
various domains relative to empty vector control; data shown is a representative of at least 
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Figure 7. Analysis of hYVHl siRNA 
(A) Cell cycle profile of control siRNA treated cells or cells where hYVHl has been 
down-regulated by siRNA presented as representative histogram data plots. HEK 293 
cells were transfected with either control siRNA or hYVHl siRNA (as indicated), 
harvested after 48hr, stained for non-transfected cells (lack of staining with endogenous 
hYVHl antibody), counterstained with propidium iodide and then subjected to a double 
colour flow cytometry analysis. (B) The graph shows the percentage change in cell cycle 
phase in cells where hYVHl has been down-regulated by siRNA relative to control 
siRNA; data shown is a representative of at least three independent experiments. (C) p-
galactosidase staining of HEK 293 cells transfected with a control siRNA or hYVHl 
siRNA. Cells were cultured for two, five and seven days. Arrows indicate positive blue 
cells. (D) Graphical presentation of the p-galactosidase staining of senescent cells. Data 
shown is a representative of three independent experiments. (E) Anti-hYVHl 
immunoblot analysis of untransfected cells, cells transfected with siRNA control and 
hYVHl siRNA and corresponding anti-actin immunoblot. 
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Discussion 
We have discovered that the expression of hYVHl alters the cell cycle profile of 
asynchronized HEK 293 cells. While the phosphatase activity seems to be dispensable 
for this property, the zinc binding domain is necessary and sufficient to elicit this 
response. Although this study is the first report to implicate hYVHl as a cell cycle 
regulator, other atypical DUSPs have been suggested to act as important positive and 
negative regulators for cell cycle progression. For example, expression of VHR (DUSP3), 
has been shown to be most abundant in mitotic cells [26]. Down-regulation of VHR is 
accompanied by loss of entry into S phase, thus triggering cell cycle arrest [26]. Down-
regulation of laforin results in a significant increase in the number of cells at S and G2/M 
phases, thus promoting cell growth [27], Similarly, down-regulation of DUSP11, also 
results in increased proliferation [28]. 
IMAC purification coupled to MALDI-TOF MS yielded the first ever identified 
phosphorylation sites for any YVHl orthologue. The two phosphorylation sites that 
affected hYVHl localization and cell cycle progression are located at the termini of 
hYVHl. The location of the phosphorylation sites is not surprising since the termini of 
proteins is a common site for protein phosphorylation including cell cycle regulators p53 
[29], histone H3 [30] and cdc2 [31]. Since phosphorylation often regulates enzyme 
activity, we did initially examine if these sites affected phosphatase activity. However, 
we saw no difference in phosphatase activity upon treatment with calyculin A using the 
exogenous fluorescent substrate DiFMUP (data not shown). Instead, our results suggest 
that both the N-terminal Serl4 and C-terminal Ser335 phosphorylation sites play a role in 
112 
regulating the subcellular localization of hYVHl and in augmenting the cell cycle 
phenotype exhibited by hYVHl over-expression. 
Analysis of the conservation of the phosphorylation sites amongst YVHl 
orthologues suggests that regulatory phosphorylation may be specific for mammalian 
orthologues. In particular, the Serl4 phosphorylation site within the N-terminal region of 
hYVHl is not conserved in yeast or rodents but is present in some advanced vertebrates 
including the primate orthologues, suggesting that this site has arisen more recently and 
may induce novel regulatory control on hYVHl function. The Ser335 phosphorylation 
site on the other hand is extensively conserved in mammals (including rodents) but is 
absent in yeast. Furthermore, the Ser335 phosphorylation site located five amino acids 
from the C-terminus resides in a so called SQ site. This consensus sequence is targeted by 
members of the phosphatidyl-inositol-3-kinase protein kinase family, including ATM 
(ataxia telangiectasia mutated), ATR (ATM and Rad3 related) and DNA-PK (DNA-
protein kinase) [32]. Interestingly, under normal cell culture conditions, ATM may 
become activated by calyculin A or okadaic acid treatment without the need for DNA 
damage [33]. This activity is cell cycle dependent and at a maximum level during G2/M 
[34] and upon nocodazole and taxol induced mitotic stress [35]. Thus since both okadaic 
acid and calyculinA treatment increased hYVHl phosphorylation, and hYVHl over-
expression increased the percentage of cells in G2/M, it will be important to examine if 
Ser335 phosphorylation occurs in a G2/M specific manner. Moreover, we are interested in 
testing if ATM is the upstream kinase responsible for hYVHl phosphorylation at Ser335. 
Our preliminary experiments demonstrated that a JNK inhibitor reduced the 
phosphorylation of hYVHl. The third phoshorylation site identified, Thr252, located 
within the Zn-binding domain, is a proline directed site, the minimum consensus site for 
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JNK. Also, hYVHl has been shown to play a role in protecting cells from various 
cellular stresses including hydrogen peroxide, heat stress, and Fas receptor activation 
[18]. Since these cellular insults are known JNK activators [36] we are particularly 
interested in examining if JNK can directly phosphorylate Thr252. 
A large scale experiment targeted at identification of subunits involved in yeast 
ribosomal biogenesis (60S pre-ribosomal particles), identified YVHl from Arxl- and 
Kre35-TAP tag pull down screens by tandem mass spectrometry [15]. As Arxl displays 
nucleoplasm^ and also cytoplasmic localization and Kre35 exhibits cytoplasmic 
distribution with nuclear exclusion [15], this is in accordance with herein reported 
distribution of Flag-hYVHl. In the 60S ribosomal biogenesis pathway, the early pre-60S 
particles are restricted to the nucleolus, the later particles are released into the 
nucleoplasm and then exported into cytoplasm [37]. As the nonphosphorylatable N- and 
C-terminal mutants displayed predominantly nuclear localization pattern, this suggests a 
possibility that the phosphorylation event could be the underlying mechanism required for 
loading onto pre-60S prior to nuclear export, thus controlling one of the late maturation 
steps in the 60S biogenesis pathway. We are currently investigating if the hYVHl 
phosphorylation mutants affect 60S subunit association and the rate of ribosome 
biogenesis. 
One of the characteristic features observed upon over-expression of the 
phosphorylation site mutants was an aberrant nuclear morphology phenotype 
accompanied by an increased proportion of cells with an increased DNA content as 
detected by flow cytometry. Moreover, knocking down hYVHl expression resulted in the 
opposite cell cycle phenotype (increase in Go/Gi) along with an increase in cellular 
senescence. Deletion of YVHl in yeast has been associated with slow-growth phenotype 
114 
[9, 11, 12, 16, 17, 24] and a delay in nuclear pre-ribosomal RNA processing, through 
impaired nuclear export of 60S subunit [16, 17, 24]. These observations suggest that 
hYVHl over-expression may contribute to genomic instability, a hallmark of cancer. 
Consistent with this, an increase in DNA copy numbers of the physical location of human 
hYVHl at lq [9], has been observed in numerous cancers, including retinoblastoma [38], 
liposarcomas [39], and intracranial ependymoma [40]. hYVHl was proposed to be 
oncogenic in the latter subset of cancers [40]. 
The exact mechanism by which hYVHl affects DNA content is still unclear. One 
possibility is that hYVHl over-expression forces endoduplication, where cells undergo 
repeated rounds of genomic DNA synthesis without an intervening mitosis, producing 
polyploid cells [41]. Alternatively, the increased DNA content may reflect a failure of 
cytokinesis or uncontrolled DNA replication. It is tempting to speculate, that highly 
regulated hYVHl expression is necessary for normal progression through cell cycle, as 
both, over-expression and down-regulation, affect cell cycle profiles. 
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CHAPTER 5 
Conclusions and Future Directions 
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In conclusion, the work presented here displays the applicability of MS-based 
approaches to various biological systems. This powerful analytical tool was used not only 
to identify a novel protein from Artemia franciscana, a model organism for which the 
genome sequence is not available (Chapter 2), analyze cysteine modifications on protein 
disulfide isomerase due to changes in the redox state (Chapter 3), but also to discover 
hYVHl residues modified by phosphorylation (Chapter 4). In each of these cases the data 
generated by mass spectrometry provided a valuable and initial step in the quest for the 
functional significance of these proteins. 
The capability of MS-based approaches to de novo identify a 21 kDA protein from 
A. franciscana diapaused embryos as a group 1 LEA protein [1] identified for the first 
time the presence of group 1 LEA proteins in animals. Until our discovery, the group 1 
LEA proteins were only described for non-animal species [2, 3]. Our observations also 
support a role for the group 1 LEA protein in desiccation tolerance in A. franciscana 
encysted embryos [1]. As encysted embryos of brine shrimp A. franciscana are one of the 
most resistant organisms to withstand extreme environmental conditions, including the 
almost complete loss of water [4], our work sheds further light onto molecular 
mechanisms governing this process. Furthermore, the sequence assignment to the 21 kDa 
protein allowed the generation of antibodies, which have led to the identification of 
multiple group 1 LEA proteins in A. franciscana encysted embryos. We have recently 
submitted an additional manuscript in this regard. 
A combination of an in vitro isotopic labelling technique and MS-based analysis 
was employed in order to assess relative changes in the dynamic thiol and disulfide states 
of recombinant human protein disulfide isomerase, PDI [5]. ICAT labelling allowed the 
monitoring of changes in the redox states of individual cysteine residues within PDI 
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under auto-oxidation conditions. As PDI contains four cysteines within two active sites 
and two cysteines within the so-called b' domain, ICAT labelling of the active site 
cysteines supported previously suggested non-equivalency between these active sites [6, 
7]. As the possibility exists, that different environmental stress conditions affect the redox 
status and thus activity of PDI, the approach described with minor modifications would 
be an invaluable tool in future experiments. 
As the major focus of Dr. Vacratsis' laboratory is the study of atypical dual 
specificity phosphatases, particularly hYVHl, a more detailed overview of future 
experiments regarding this protein is provided. 
To our knowledge, the work described herein on the identification and 
characterization of hYVHl (DUSP 12) phosphorylation sites, is novel for this family of 
proteins. Identification of these sites provides a basis for several lines of future 
investigation. For example, one of the next rational steps is to generate phosphospecific 
antibodies, which will further facilitate characterization of the functional significance of 
these sites. Additionally, cell cycle synchronization experiments, achieved upon drug 
treatments, such as double thymidine block for Gi/S, mimosine for Gi and nocodazole for 
M phase [8] or by release from double thymidine block, will be a useful approach to 
address phosphorylation dependent changes in the localization pattern of hYVHl at the 
endogenous level. As hYVHl displays nuclear, perinuclear and cytoplasmic localization 
[9-11] a possibility exists, that these localization patterns are cell cycle dependent. 
Furthermore, as the identified phosphorylation sites affect the progression through cell 
cycle, the use of phosphospecific antibodies will allow the detection of the sub-population 
of cells that are phosphorylated at these specific sites by the analysis of their DNA 
content by flow cytometry. Last, but not least, the possibility exists, that the 
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phosphorylation at these sites might be upregulated in response to stress (and 
downregulated by treatment with specific inhibitors) or differentially expressed in 
different cell lines. In order to address these possibilities, phosphospecific antibodies are 
valuable tools that will allow the determination of relative phosphorylation levels by 
western blot analysis of total cellular lysates from cells under various conditions. hYVHl 
has also been shown to be overexpressed in chronic myelogenous leukemia [12] and 
amplification of the hYVHl gene region has been detected in numerous cancers [13-15]. 
Thus the use of phosphospecific antibodies in analysis may provide clues as to whether 
phosphorylation of these sites is correlated with disease. Furthermore, our results suggest 
that several of these sites are important for the generation of DNA content changes in 
cells upon hYVHl over-expression. The question is, do they act similarly in 
malignancies? This may be in part accomplished by an immunohistochemistry screen of 
commercially available core patient biopsies attached onto a microscope slide. 
One of the limitations associated with phosphospecific antibodies is their 
insufficient performance in immunoprecipitation assays. As there is the possibility, that 
phenotypes associated with over-expression of the phosphomutants are caused either by 
novel protein-protein interactions or disruption of a critical protein-protein complexes, a 
MS-based TAP-tag approach would allow the identification of novel interacting partners. 
The TAP-tag method is efficient at the identification of interacting partners at sub-
stoichiometric levels [16] and was introduced in detail in Chapter 1. Since over-
expression of hYVHl has shown to result in an increased DNA content, wild-type 
hYVHl and phosphomimetic S14E and S335E mutants expressed from a TAP-tag vector 
will be analyzed in unsynchronized and synchronized cells, as the over-expression has 
shown an increase in DNA content. Alternatively, to address the possibility that any of 
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the potential interacting partners are hYVHl substrates, an additional mutation of 
catalytic aspartic acid to alanine (D84A) will be introduced into these phosphomutants 
thus modifying them into "substrate-traps". The "substrate-trap" mutation impedes the 
substrate dephosphorylation process. It is noted that while the phosphatase-substrate 
complex is still formed, the subsequent cleavage of the thiol phosphate bond initiated by 
the nucleophilic cysteine cannot take place without the catalytic acid/base (Asp84), thus 
rendering the substrate attached and stable enough to withstand isolation [17]. In order to 
reduce the complexity of immunoprecipitated proteins, separation will be performed 
either by SDS-PAGE or MudPIT-base method [18] (and introduced in detail in Chapter 
1). The latter option has recently become a feasible alternative with the acquisition of a 
nano-spray triple quadrupole tandem MS instrument in our laboratory. 
The three dimensional structure of proteins, experimentally elucidated either from 
x-ray crystallography or NMR studies, provide invaluable insight on how structure 
dictates functions. To date, crystal structures of only three atypical DUSPs have been 
elucidated, including VHR (DUSP3) [19], JKAP (DUSP22) [20] and VHZ (DUSP23) 
[21]. All of these are relatively small proteins and contain only the catalytic domain. As 
hYVHl is the only DUSP that contains a phosphatase catalytic domain and a zinc binding 
domain, this further complicates calculations for the computational homology model. Dr. 
Vacratsis' laboratory is currently in the process of elucidating the x-ray structure of 
hYVHl (DUSP12) in collaboration with Dr. B. Crane (Cornell University). One of the 
unpredictable properties of proteins is their refractory nature to crystallization, requiring a 
long process of optimization. Thus in the meantime, MS-based methods such as the cross-
linker MS approach can identify peptides that are spatially close in a folded protein. 
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Cross-linked peptides identified from MS-analysis of isotopically labelled cross-
linked protein are indicative of the spatial proximity of two linked amino acids at the time 
of cross-linking [22, 23]. Upon labelling of intact proteins with a mixture of isotopically 
labelled 'heavy' disuccinimidyl suberate (DSS) containing 12 deuteriums (Di2DSS) [23] 
and commercially available Tight' D0DSS, cross-linker-modified peptides are detected by 
presence of isotopic shift between labelled fragment ion peaks. Experimental evidence 
indicated, that DSS formed peptide-peptide links connected mostly lysine residues [22]. 
After cross-linking the amino acids within the protein and prior to proteolysis, disulfide 
bonds were reduced, and thiol groups were alkylated with iodoacetamide. The use of 
trypsin to generate peptide fragments has two advantages; first, cleavage does not occur at 
the lysine residues participating in the cross-links, thus this miscleavage is included as a 
pre-selection criteria; and second, the ability to enrich cross-linked peptide by strong 
cation exchange chromatography. Fractionation steps prior to MS-analysis are necessary, 
especially in a complex sample, as the cross-linked peptides are present at low 
stoichiometry and occur at low frequency compared to unmodified peptides [22]. This 
method is applicable to both MALDI [23] and electrospray ionization [22] based MS-
instruments. With the latter instrumental set up, the majority of detected cross-linked 
peptides have a charge state greater than +3 [22], thus this property can be incorporated 
into criteria for inclusion list of peptides selected for MS/MS analysis. 
hYVHl contains eleven lysine residues within the catalytic domain and nine 
lysine residues within the zinc binding domain, thus with this MS-based approach the 
interaction interface between these two domains should be identifiable. If the sensitivity 
and detection power of our MALDI-TOF instrument is insufficient for the proposed 
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experiments, a nano-spray triple quadrupole mass spectrometer, the newest addition to 
our department will be invaluable. 
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Rigfrtslink Printable License lirtps://slOO.copyiî it.c<)ro,'App'Prii*ibleLicenseFrairB.jsp?|>ublislierID... 
material to be stored in a central repository such as that provided by Heron/XanEdu. 
19. Website (regular and for author): A hyper-text must be included to the Homepage of the 
journal from which you are licensing al littp://www,scicncedirect.com/scienee/iourna] 
/xxxxx. or for books to the Elsevier homepage at http://www.elsevier.com 
20. Thesis/Dissertation: If your license is for use in a thesis/dissertation your thesis may be 
submitted to your institution in either print or electronic form. Should your thesis be 
published commercially, please reapply for permission. These requirements include 
permission for the Library and Archives of Canada to supply single copies, on demand, of 
the complete thesis and include permission for UMI to supply single copies, on demand, of 
the complete thesis. Should your thesis be published commercially, please reapply for 
permission. 
21. Other Conditions: None 
Vl.6 
Gratis licenses (referencing $0 in the Total field) are free. Please retain this printable 
license for your reference, No payment Is required. 
If you would like to pay for this license now, please remit this license along with your 
payment made payable to "COPYRIGHT CLEARANCE CENTER" otherwise you will be 
invoiced within 48 hours of the license date. Payment should be in the form of a check 
or money order referencing your account number and this invoice number 
RLNK10775121. 
Once you receive your invoice for this order, you may pay your invoice by credit card. 
Please follow instructions provided at that time. 
Make Payment To: 
Copyright Clearance Center 
Dept 001 
P.O. Box 843006 
Boston, MA 02284-3006 
If you find copyrighted material related to this license will not be used and wish to 
cancel, please contact us referencing this license number 2417270439001 and noting 
the reason for cancellation. 
Questions? customercare@copvriaht.com or +1-877-622-5543 (toll free in the US) or 
+ 1-978-646-2777. 




Education: University of Windsor, Windsor, Ontario 
2005-2010 (Ph.D.) 
Laurentian University, Sudbury, Ontario 
2002-2004 (M.Sc.) 
McMaster University, Hamilton, Ontario 
1997-2000 (B.Sc.) 
Employment: Samuel Lunenfeld Research Institute, Toronto, Ontario 
2000-2002 
136 
